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ABSTRACT 
Resistance to flavivirus-induced disease is conferred by a single gene that encodes 
oligoadenylate synthetase (Oas) 1b (Oas1b). Oas1b is not a functional synthetase suggesting its 
anti-flavivirus mechanism is RNase L-independent and that it may be mediated by interactions 
with other host cell protein(s). A yeast two-hybrid screen was used to identify host cell binding 
partners of Oas1b. Candidate partners were confirmed by yeast co-transformation and co-
immunoprecipitation analyses. Oxysterol binding protein-related 1L (ORP1L) and ATP binding 
cassette subfamily F 3 (ABCF3) were found to interact with Oas1b. RNAi knockdown studies 
suggested that ORP1L and ABCF3 form a tripartite complex with Oas1b that is critical for the 
flavivirus-induced disease resistance mechanism. 
  
 
Stresses including oxidation, nutrient starvation, and viral infections often induce the 
formation of stress granules (SGs) in eukaryotic cells. In response to stress, eIF2α kinases 
phosphorylate eIF2α leading to stalled 48S pre-initiation complexes and SG formation. West 
Nile virus (WNV) Eg101 infections were previously shown not to induce the formation of SGs. 
Infections with viruses of other natural WNV strains, as well as a WNV lineage 1/2-based 
infectious clone (W956IC) were analyzed and only W956IC infections were found to induce 
SGs. eIF2α kinase knockout MEFs were used to show that the W956IC-induced SGs were PKR-
dependent. WNV chimeras were made by inserting Eg101 genes into the W956IC backbone. 
Chimeras replacing NS5 or NS1 and NS5 or NS1 and NS3 and NS4a reduced SG formation as 
well as early viral RNA synthesis similar to Eg101 infections. W956IC infections but not Eg101 
infections were shown to produce exposed viral dsRNA at early times after infection. The data 
suggest that natural WNV infections evade the cell SG response by suppressing the amplification 
of viral RNA until cytoplasmic membranes have been remodeled to protect replication 
complexes from detection. 
It was previously reported that WNV Eg101 infections inhibited the formation of 
arsenite-induced SGs. The ability of other natural WNV strain infections to inhibit SG formation 
by arsenite (HRI), DTT (PERK), W956IC co-infection (PKR), and heat shock treatments was 
assessed. WNV infections only inhibited arsenite-induced SG formation suggesting that WNV 
infections specifically suppress the response to oxidative intermediates. 
 
INDEX WORDS: West Nile virus, 2′-5′ Oligoadenylate synthetase 1b (Oas1b), Oxysterol 
binding protein-related protein 1L (ORP1L), ATP binding cassette subfamily F 3 (ABCF3), 
Small hairpin RNA (shRNA), Stress granule, eIF2α, PKR, Chimera.  
  
 
FUNCTIONAL ANALYSIS OF HOST CELL PROTEINS AND STRESS RESPONSES THAT 
INHIBIT WEST NILE VIRUS INFECTION 
 
by 
 
SEAN CHRISTOPHER COURTNEY 
 
 
 
 
 
 
 
 
 
 
 
 
A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of  
Doctor of Philosophy 
in the College of Arts and Sciences 
Georgia State University 
2011  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by  
Sean Christopher Courtney 
2011 
  
 
FUNCTIONAL ANALYSIS OF HOST CELL PROTEINS AND STRESS RESPONSES THAT 
INHIBIT WEST NILE VIRUS INFECTION 
 
by 
 
SEAN CHRISTOPHER COURTNEY 
 
 
 
Committee Chair: Margo A. Brinton 
Committee: John Houghton 
Irene Weber 
 
 
 
 
 
Electronic Version Approved: 
 
Office of Graduate Studies 
College of Arts and Sciences 
Georgia State University 
December 2011 
iv 
 
 
DEDICATION 
 I dedicate this dissertation to my family and loved ones. To my parents, Chris and Donna 
Courtney, who have always pushed me to work hard and never give up in order to achieve my 
life goals. With your unconditional love you have always provided me the environment, 
opportunity and passion to be the best at anything I attempt. To my sister Jill and her family, 
Jason, Taylor and Brooks, I want to thank you all for always finding a way to make me laugh. 
You all bring so much joy to my heart. To my dearest friends, Montez Bynum and Ryan Butts, 
you have both been integral to my journey and I love you each dearly. Thank you all for being 
there for me when times were tough and always finding a way to keep me focused. Without 
every one of you none of this would have been possible and I want to personally thank you each 
of you because your support has been truly amazing. I love you all. 
 
 
“Some people drink from the fountain of knowledge...others just gargle.” 
~Robert Anthony 
 
“Stay thirsty my friends!” 
~The Most Interesting Man in the World (Dos Equis) 
 
 
  
v 
 
 
ACKNOWLEDGEMENTS 
 I would like to extend my sincerest gratitude to my principle advisor, Dr. Margo A. 
Brinton. Thank you for the experiences you have provided me within this lab, along with your 
support, patience, expert advice and trust. I would also like to thank my committee members Dr. 
John Houghton and Dr. Irene Weber for your skillful assistance and knowledgeable suggestions. 
The three of you have given me the utmost confidence to succeed as a scientist. I would 
especially like to thank Dr. Svetlana Scherbik for all of her assistance and patience, but even 
more for her great friendship. Lastly, I would like to thank all of the members of the Brinton lab, 
past and present, for all of their support and camaraderie through the years. 
  
vi 
 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS                   v 
LIST OF TABLES                  xi 
LIST OF FIGURES                 xii 
LIST OF ABREVIATIONS               xiv 
CHAPTER 1                     1 
INTRODUCTION .............................................................................................................. 1 
 1.1   Classification and Clinical Significance of Flaviviruses ..................................... 1 
 1.2   Flavivirus Replication Cycle ................................................................................. 2 
 1.3   Flavivirus Genome ................................................................................................. 4 
 1.4   Structural Proteins ................................................................................................. 4 
 1.5   Viral Nonstructural Proteins (NS) ........................................................................ 6 
 1.6   Host Genetic Resistance/Susceptibility to Virus-Induced Disease ................... 11 
 1.6.1   Genetic Resistance due to Blocking Viral Entry ..................................... 12 
 1.6.2   Genetic Resistance due to Intracellular Effectors................................... 12 
1.6.3   Genetic Resistance due to Recognition and Destruction by Immune   
Cells ............................................................................................................. 14 
 1.7   Stress Granules ..................................................................................................... 18 
 1.8   Virus-Induced Stress Granule Formation ......................................................... 19 
GOALS OF THIS DISSERTATION .............................................................................. 23 
vii 
 
 
1.9   Specific Aim 1: To identify and characterize unique cellular binding partners of 
Oas1b and to analyze the involvement of selected Oas1b interaction partners 
in the West Nile virus infection cycle ................................................................ 23 
1.10   Specific Aim 2: To analyze the formation of virus-induced stress granules 
during infection of BHK cells with a WNV lineage 2-based infectious clone 23 
CHAPTER 2                   24 
Specific Aim 1: To identify and characterize unique cellular binding partners of 
Oas1b and to analyze the involvement of selected Oas1b interaction partners 
in the West Nile virus infection cycle ................................................................ 24 
INTRODUCTION ............................................................................................................ 24 
RESULTS .......................................................................................................................... 26 
 2.1    Identification of putative Oas1b binding partners in a yeast two-hybrid   
screen .................................................................................................................... 26 
 2.2    Co-immunoprecipitation of putative binding partners and Oas1b ................ 29 
 2.3    The effect of reducing ORP1L protein levels on virus infections ................... 33 
 2.4    The effect of reducing ABCF3 protein levels on virus infections ................... 38 
DISCUSSION .................................................................................................................... 43 
MATERIALS AND METHODS ..................................................................................... 47 
 2.5    Cell Lines .............................................................................................................. 47 
 2.6    cDNA Contructs .................................................................................................. 48 
 
viii 
 
 
 2.7    Transient Transfection ....................................................................................... 50 
 2.8    Viruses .................................................................................................................. 50 
 2.9    Plaque Assay ........................................................................................................ 50 
 2.10  Yeast Two-Hybrid Analysis................................................................................ 51 
 2.11  Yeast Co-transformation .................................................................................... 51 
 2.12  In Vitro Transcription and Translation ............................................................ 52 
 2.13  In vitro Co-immunoprecipitation ....................................................................... 52 
 2.14  Mammalian Cell Co-immunoprecipitation ....................................................... 53 
 2.15  Antibodies ............................................................................................................ 54 
 2.16  Confocal Microscopy .......................................................................................... 54 
 2.17  Real time qRT-PCR ............................................................................................ 55 
 2.18  MTT Assay ........................................................................................................... 55 
CHAPTER 3                   56 
Specific Aim 2: To analyze the formation of virus-induced stress granules during 
infection of BHK cells with a WNV lineage 1/2-based infectious clone ......... 56 
INTRODUCTION ............................................................................................................ 56 
RESULTS .......................................................................................................................... 58 
 3.1   Efficiency of SG formation induced by different strains of WNV ................... 58 
 3.2   Stress granule formation in WNV-infected cells is PKR-dependent ............... 62 
ix 
 
 
 3.3   W956IC infections induce higher levels of phosphorylated PKR and 
phosphorylated eIF2α in BHK cells at early times after infection  ................ 67 
 3.4   Mapping the viral determinants involved in enhanced SG induction by 
W956IC virus infection....................................................................................... 69 
 3.5   Enhanced early viral RNA synthesis in W956IC-infected cells results in 
cytoplasmic exposure of viral dsRNA ............................................................... 75 
DISCUSSION .................................................................................................................... 77 
MATERIALS AND METHODS ..................................................................................... 81 
 3.6   Cells ....................................................................................................................... 81 
 3.7   Viruses ................................................................................................................... 82 
 3.8   Construction of chimeric viruses ........................................................................ 82 
 3.9   Confocal Microscopy ........................................................................................... 83 
 3.10   SG-Positive Infected Cell Quantification ......................................................... 84 
 3.11   Quantification of viral RNA .............................................................................. 84 
 3.12   Western blotting ................................................................................................. 85 
 3.13   Plaque Assay ....................................................................................................... 85 
 3.14   MTT Assay .......................................................................................................... 85 
ADDITIONAL DATA ...................................................................................................... 86 
CHAPTER 4                   96 
SIGNIFICANCE/FUTURE DIRECTIONS................................................................... 96 
x 
 
 
 4.1   Oas1b-Mediated Resistance to Flavivirus-Induced Disease ............................. 96 
 4.2   SG Formation During WNV Infections ........................................................... 105 
REFERENCES                107
xi 
 
 
LIST OF TABLES 
Table 2.1 Oas1bΔTM Yeast Two-Hybrid Analysis Results 30
xii 
 
 
LIST OF FIGURES 
Figure 1.1    Flavivirus Replication Cycle 3 
Figure 1.2    Schematic representation of the WNV polyprotein 5 
Figure 1.3    Schematic representation of the OAS-RNase L innate immune response 
pathway 16 
Figure 1.4   Schematic representation of full length and truncated Oas1b 17 
Figure 1.5   Canonical pathway for the formation of stress granules 20 
Figure 2.1   Full length Oas1b contains a transmembrane domain that localizes it to the ER 
membrane 28 
Figure 2.2   In vitro co-immunoprecipitation of Oas1bΔTM and putative partner peptides 
16-1 (Orp1L) and 42-3-5 (Abcf3) 32 
Figure 2.3   Mammalian cell co-immunoprecipitation of V5-tagged Orp1L and endogenous 
Abcf3 with FLAG-tagged Oas1b 34 
Figure 2.4   The effect of Orp1L knockdown on WNV infection in KI MEFs stably 
expressing shRNAs targeting Orp1L 36 
Figure 2.5   The effect of Orp1L knockdown on Sindbis virus and vesicular stomatitis virus 
infections 37 
Figure 2.6   The effect of Abcf3 knockdown on WNV infection in KI MEFs stably 
expressing shRNAs targeting Abcf3 39 
Figure 2.7   The effect of Abcf3 knockdown on SinV and VSV infections 41 
Figure 2.8   The effect of Abcf3 knockdown on WNV infection in B6 MEFs stably 
expressing shRNAs targeting Abcf3 42 
Figure 3.1   Stress granule formation induced by different strains of WNV 60 
xiii 
 
 
Figure 3.2   Stress granule formation induced by WNV infection is PKR-dependent 63 
Figure 3.3   WNV Eg101 and W956IC infections replicate to higher levels in PKR
-/-
 MEFs
 66 
Figure 3.4   W956IC-infected cells have elevated levels of phosphorylated PKR and eIF2α
 68 
Figure 3.5   Schematic representation of the WNV W956IC-Eg101 chimera genomes 70 
Figure 3.6   The levels of early viral RNA synthesis correlate with the level of SG-positive, 
infected cells and virus yield 73 
Figure 3.7   Exposed viral dsRNA was detected in 0.01% Triton X-100 permeabilized 
W956IC-infected but not Eg101-infected cells 76 
Figure 3.8   The effect of infections with various WNV strains on arsenite-induced, HRI-
mediated SG formation 87 
Figure 3.9   The effect of various WNV strain infections on DTT-induced, PERK-mediated 
SG formation 90 
Figure 3.10   The effect of various WNV strain infections on W956IC-induced, PKR-
mediated SG formation 92 
Figure 3.11 The effect of various WNV strain infections on heat shock-induced SG 
formation 94 
Figure 3.12 The effect of WNV NS5 protein expression on arsenite-induced SG formation
 95 
Figure 4.1   Proposed model of the Oas1b-ABCF3-ORP1L protein complex 103 
  
xiv 
 
 
LIST OF ABREVIATIONS 
Dengue virus (DEN) 
Yellow fever virus (YFV) 
Japanese encephalitis virus (JEV) 
West Nile virus (WNV) 
Sindbis virus (SinV) 
Vesicular stomatitis virus (VSV) 
Open Reading Frame (ORF) 
Endoplasmic Reticulum (ER) 
Envelope (E) 
Membrane (prM, M) 
Capsid (C) 
Nonstructural Protein (NS) 
RNA-binding domain (RBD) 
Virus-like particles (VLPs) 
Interferon (IFN) 
Nucleoside triphosphatase (NTPase) 
RNA triphospatase (RTPase) 
Methyltransferase (MTase) 
RNA-dependent RNA polymerase (RdRp) 
Oligoadenylate synthetase (OAS) 
Oligoadenylate synthetase 1b (Oas1b) 
Truncated Oas1b (Oas1bt) 
xv 
 
 
Oas1b with a deletion of the C-terminal Transmembrane domain (Oas1bΔTM) 
Oxysterol binding protein-related protein 1L (Orp1L) 
ATP binding cassette (ABC) 
ATP binding cassette subfamily F 3 (Abcf3) 
Mouse embryofibroblasts (MEFs) 
Baby Hampster Kidney (BHK) 
Viral RNA (vRNA) 
Multiplicity of infection (MOI) 
Late endosomes (LEs) 
Rab7-interacting lysosomal protein (RILP) 
Vesicle associated membrane protein (VAMP)-associated protein (VAP-A) 
Eukaryotic translation initiation factor 2α (eIF2α) 
Protein Kinase R (PKR) 
PKR-like ER-associated eIF2α kinase (PERK) 
Heme-regulated initiation factor 2α (HRI) 
General control nondepressible 2 (GCN2) 
T cell intracellular antigen 1 (TIA-1) 
TIA-1-related (TIAR) 
Ras GAP SH3 domain binding protein (G3BP) 
Stress granules (SGs) 
Processing bodies (PBs) 
Internal ribosome entry site (IRES) 
Double-strand RNA (dsRNA) 
xvi 
 
 
Lineage 2/1-based WNV infectious clone virus (W956IC) 
2-Aminopurine (2-AP) 
Pathogen recognition receptor (PRR) 
 
 
  
1 
 
 
CHAPTER 1 
INTRODUCTION 
Classification and Clinical Significance of Flaviviruses 
The family Flaviviridae contains three genera, Flavivirus, Pestivirus, and Hepacivirus, 
and the unclassified hepatitis G viruses. The genus Flavivirus consists of about 60 viruses and 
includes human pathogens such as dengue virus (DEN), yellow fever virus (YFV), Japanese 
encephalitis virus (JEV), and West Nile virus (WNV) (Lindenbach, 2007). West Nile virus was 
first isolated in Uganda in 1937 and the majority of the more than 70 strains have been classified 
into two distinct lineages based on sequence homology. Lineage 1 WNV strains are endemic in 
northern Africa, Europe, India, the Middle East, Asia and North America, while lineage 2 WNV 
strains are typically found in sub-Saharan Africa (Bakonyi et al., 2006; Hayes et al., 2005; 
Knipe, 2007; Lanciotti et al., 2002). As of late 2006, the Centers for Disease Control (CDC) had 
reported over 23,000 cases of human WNV infection within the United States (Sejvar, 2007).  
WNV is arthropod-borne and its transmission cycle in nature is usually between Culex 
mosquito species and birds; however, transmission of WNV to horses and humans by mosquitoes 
occurs occasionally (Brinton, 2002). WNV infectious particles present in the salivary glands of 
infected mosquitoes are transmitted to vertebrate hosts during a blood meal. Initially, the virus 
replicates at the site of infection and then moves to the regional lymph nodes. Once in the lymph 
nodes, the virus can disseminate into the vascular system, spread to peripheral organs and in 
some cases, cross the blood brain barrier. WNV is part of the Japanese encephalitis serocomplex 
and is known to attack the central nervous system, particularly the medulla of the brainstem 
(Brinton, 2002). WNV infection usually produces asymptomatic or mild disease with symptoms 
that can include fever, headache, body rash, muscle fatigue, and disorientation (Brinton, 2002). 
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About 1 in 150 or fewer infected individuals develop more severe diseases such as encephalitis, 
hepatitis and polio-like syndromes (Brinton, 2002). The infection usually clears within about 3-6 
days; however, about 10% of those with severe illness can have a fatal outcome with older and 
immunocompromised individuals having a higher incidence of mortality. 
 
Flavivirus Replication Cycle 
WNV replicates in a wide range of cell cultures including primary chicken, duck, and 
mouse embryo cells and continuous cell lines from monkeys, humans, pigs, rodents, amphibians, 
and insects (Brinton, 1986). The life cycle of flaviviruses occurs entirely within the cytoplasm of 
infected cells (Figure 1.1). Entry of the virion into cells is mediated through the interaction of the 
E protein with an unknown receptor(s). The virion is endocytosed at clatherin-coated pits, 
transported to prelysosomal vesicles, and low pH-induced fusion of the virion and vesicle 
releases the viral nucleocapsid (Chu et al., 2006; Chu and Ng, 2004; Heinz and Allison, 2000; 
Heinz et al., 2004). After release, the viral genome acts as a messenger RNA (mRNA) and 
immediately begins translation of the single open reading frame (ORF) to produce the viral 
polyprotein. The viral polyprotein is cleaved co- and post-translationally by both cellular and 
viral proteases (Lindenbach, 2007). Replication of the viral genome occurs within vesicular 
invaginations of the ER membrane that open to the cytoplasm through a small pore (Kim et al., 
2004; Welsch et al., 2009). The nascent viral genomic RNA exits these vesicle structures and is 
either translated by neighboring ribosomes or bound to capsid proteins attached to opposing ER 
membrane which also contain viral envelope (E) and membrane (prM) proteins. The capsid 
protein encapsidates the viral genome and produces the immature virion within the lumen of the 
ER (Welsch et al., 2009).  Immature  virions  traverse  the  ER  and  trans-Golgi  network,  
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Figure 1.1. Flavivirus Replication Cycle. (A) Virion attachment, entry, and fusion and 
uncoating of the viral genome RNA. (B) Translation of the viral RNA. (C) Proteolytic 
processing of the viral polyprotein into the individual viral proteins. D) Synthesis of the 
complementary viral minus strand RNA. (E) Synthesis of the genome RNA from the template 
minus strand RNA. (F) Encapsidation and assembly of immature virions in the ER. (G) 
Processing of prM to M to produce mature virions in the trans-Golgi network. (H) Fusion of 
virion-containing vesicles and the plasma membrane resulting in release of infectious virus 
particles from the cell. Modified figure and legend adapted from (Brinton, 2008). 
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concurrently maturing via the cleavage of prM to M (Plevka et al., 2011). Mature virions are 
approximately 50 nm in diameter, spherical and enveloped. WNV virions are transported in 
vesicles to the plasma membrane and released by fusion of the vesicle with the plasma 
membrane (Brinton, 2002). 
 
Flavivirus Genome 
The flavivirus genome is a positive-sense, single-strand RNA (+ssRNA) with a capped 5' 
end but no 3' poly (A) tail. Flavivirus genomes are unique among mammalian positive-sense 
RNA viruses in the lack of a 3' poly (A) tail (Brinton, 2002). The flavivirus genome is about 11 
kb in length and contains one open reading frame that encodes three N-terminally located viral 
structural proteins, capsid (C), membrane (prM/M), and envelope (E), followed by seven C-
terminal nonstructural proteins, NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5 (Figure 1.2) 
(Brinton, 2002). The ten mature viral proteins are generated via proteolytic processing of the 
polyprotein by both viral and cellular proteases (Brinton, 2002). The majority of the 
nonstructural proteins are multi-functional and all seven appear to be involved in viral RNA 
synthesis (Brinton, 2002; Mackenzie et al., 1996). 
 
Structural Proteins 
 WNV virions are ~50 nm in diameter, spherical and enveloped. They are made up of 
three structural proteins: E, prM/M and capsid (C). The E and M proteins compose the exterior 
surface of the virion (Lindenbach, 2007). The E glycoprotein is required for receptor recognition 
and fusion of the virion for entry into cells; however, the cellular protein used as the WNV entry 
receptor has yet to be determined. Immature virions have trimers of prM and E heterodimers on  
5 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. Schematic representation of the WNV polyprotein. The WNV genome is 
translated into a single polyprotein that is processed co- and post-translationally by both host and 
viral proteases into 10 viral proteins. Three structural proteins (E, prM/M, and C) are encoded in 
the N-terminus while seven nonstructural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b, and 
NS5) are encoded in the C-terminus. Figure and modified legend adapted from (Brinton, 2002). 
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their surface that create spikes. The M protein is cleaved from prM by the host protease furin in  
the trans-Golgi network, which leads to a conformational change and rearrangement of the E 
proteins so that they lie flat against the envelope and form an icosahedrom shell on the outside of 
the virion (Kuhn et al., 2002).  
The mature virion particles that contain a smooth surface with icosahedral symmetry 
made up of 90 head-to-tail homodimers of E (Brinton, 2008; Kuhn et al., 2002). The virion 
capsid is about 30 nm in diameter and has no discernable geometric symmetry inside virions. 
RNA-binding domains (RBD) are found at both the N- and C-termini of the C protein and are 
separated by a hydrophobic domain that tethers the protein to the lipid bilayer membrane. 
Flavivirus-infected cells have been reported to release non-infectious virus-like particles (VLPs) 
that are composed of the E and M proteins but lack capsid and viral RNA (Ferlenghi et al., 2001; 
Takahashi et al., 2009). These data suggest that C dimers are essential for the recruitment of viral 
RNA for the formation of infectious virions; however, no encapsidation signal has yet been 
identified in the genome RNA (Brinton, 2008). The C dimers have very high net positive 
charges, suggesting that the interaction between C dimers and the viral genomic RNA is 
nonspecific. 
 
Viral Nonstructural Proteins (NS) 
 The WNV genome encodes seven nonstructural proteins, NS1, NS2a, NS2b, NS3, NS4a, 
NS4b and NS5. Each of these viral nonstructural proteins is suggested to be required for 
replication of the viral genome; however, the precise function(s) of each of these proteins within 
viral replication complexes is not known.   
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The WNV NS1 protein is a ~46 kDa glycoprotein that localizes to the ER membrane and 
cell surface, and is secreted from infected cells (Avirutnan et al., 2011; Brinton, 2008; Falgout 
and Markoff, 1995; Smith and Wright, 1985; Somnuke et al., 2011; Wilson et al., 2008). A 
correlation between the levels of secreted NS1 in the blood and disease severity has been 
observed in a hamster model (Macdonald et al., 2005). Secreted NS1 proteins from different 
flavivirus members have been reported to attenuate the antimicrobial complement pathway by 
directly binding to various complement proteins including regulatory protein H, C4, C4b binding 
protein and C1s (Avirutnan et al., 2011; Chung et al., 2006; Somnuke et al., 2011). For example, 
NS1 binding to regulatory protein H inhibits complement activation and decreases the deposition 
of complement attack complexes on infected cells (Chung et al., 2006). Secreted NS1 has also 
recently been reported to inhibit the establishment of an antiviral state by blocking TLR3-
mediated activation of IFN regulatory factor 3 and production of interleukin 6 (Wilson et al., 
2008). The precise intracellular functions of NS1 are currently unknown; however, it has been 
suggested to be involved in virus replication and has been reported to co-localize with viral 
replication complexes, likely through interactions with NS4a (Lindenbach and Rice, 1999; 
Mackenzie et al., 1996). Studies delivering NS1 protein by trans-complementation resulted in the 
recovery of virus containing a defective yellow fever virus genome and the recovery of these 
trans-complemented viruses suggested a role for NS1 in the initial synthesis of the viral minus 
strand RNA (Lindenbach and Rice, 1997). The NS1 protein contains two or three N-linked 
glycosylation sites and studies have shown that there is a reduction in viral RNA synthesis when 
these sites are mutated (Muylaert et al., 1996). Within the Japanese encephalitis virus serogroup 
of flaviviruses, a longer NS1 protein, referred to as NS1′, is produced. NS1′ is suggested to form 
by the presence of a slippery sequence near the NS1-NS2a junction that causes a -1 ribosomal 
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frameshift to occur due to a downstream psuedoknot structure (Melian et al., 2010). NS1′ was 
suggested to function in viral neuroinvasion by studies showing that removal of the pseudoknot 
structure inhibited the production of NS1′ and mice subsequently injected intraperitoneally with 
the virus produced greater than 80% survivial of encephalitis compared to mice injected with 
wildtype virus (Melian et al., 2010). 
 Infected cells contain both a ~22 kDa full length NS2a protein and a C-terminally 
truncated ~20 kDa protein (Chambers et al., 1990a; Nestorowicz et al., 1994). Again, the precise 
function(s) of NS2a in flavivirus replication is unknown but it is suggested to be a 
transmembrane protein that is involved in virus assembly and has been reported to localize with 
replication complexes and interact with NS3, NS5 and the 3′ UTR (Kummerer and Rice, 2002; 
Lindenbach, 2007; Mackenzie et al., 1998). NS2a was also shown to act as a suppressor of 
interferon-β (IFN-β) signaling when it was exogenously expressed in cells infected with 
Newcastle disease virus (NDV) and rescued the replication of the IFN-sensitive NDV (Munoz-
Jordan et al., 2003). The ~14 kDa NS2b protein is also membrane associated. Currently, NS2b 
has only been identified as a cofactor of NS3 required for viral polyprotein processing 
(Lindenbach, 2007). Both NS2a and NS2b are suggested to be transmembrane proteins that aid 
in anchoring the soluble viral NS3 protease to the replication complex. 
 The ~70 kDa flaviviral NS3 protein possesses numerous enzymatic functions. NS3 
functions as the viral serine protease and this activity is contained within an N-terminal domain 
of NS3. NS2b functions as a cofactor for the NS3 protease activity (Bessaud et al., 2006; 
Chambers et al., 1990b; Miller et al., 2006). The NS2b-NS3 protease complex cleaves the 
NS2a/2b, NS2b/NS3, NS3/NS4a, and NS4b/NS5 junctions of the viral polyprotein (Assenberg et 
al., 2009; Brinton, 2008; Lindenbach, 2007). The remainder of the NS3 sequence contains 
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homologies to RNA helicase, nucleoside triphosphatase (NTPase), and RNA triphosphatase 
(RTPase) motifs. The RNA helicase domain is a supergroup 2 RNA helicase (Gorbalenya et al., 
1989) and is proposed to hydrolyze ATP to unwind the secondary structures of the viral RNA 
(Wengler, 1991, 1993). Mutational studies specifically abolishing the RNA helicase activity of 
NS3 further confirmed the necessity of the functionality of this domain for virus growth 
(Matusan et al., 2001). The C-terminal RTPase domain is proposed to dephosphorylate the 5′ end 
of the genome to allow capping (Wengler, 1993). When overexpressed alone, the flavivirus NS3 
protein induces apoptosis in a pathway involving both caspases-8 and -3; however, this is not the 
case during an infection. NS3 also contains the main antigenic peptide determinant of MHC 
class-II molecules important for the antiviral CD8+ cytotoxic T cell response (Lobigs et al., 
1994; Ramanathan et al., 2006). 
 NS4a (~16 kDa) and NS4b (~27 kDa) are both small hydrophobic proteins and are 
connected by a 2K peptide. The precise function(s) of these proteins in viral replication is 
currently unknown but both have been shown to colocalize with the viral replication complexes 
(Mackenzie et al., 1998; Miller et al., 2006). The 2K peptide is removed by both host and viral 
proteases and a mutation at the 9
th
 residue (Val to Met) of the 2K peptide has been reported to 
confer resistance to lycorine, a flavivirus inhibitor, as well as rescuing viral growth in Oas1b-
expressing cells (Mertens et al., 2010; Zou et al., 2009). It has been reported that the cleavage of 
the 2K peptide is an important step for membrane rearrangement, likely essential for replication 
complex formation (Miller et al., 2007; Roosendaal et al., 2006). Overexpression of recombinant 
NS4a protein alone was shown to induce membrane rearrangement that slightly differed from 
virus-induced membrane rearrangements, suggesting that NS4a is the main viral protein involved 
in this function but other cell factors may also be involved in inducing membrane rearrangement 
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during flavivirus infections (Roosendaal et al., 2006). Similar to NS2a, NS4a and NS4b were 
both shown to act as IFN signaling antagonists, with NS4b being the most suppressive (Munoz-
Jordan et al., 2005; Munoz-Jordan et al., 2003). In addition, the co-expression of NS2a, NS4a 
and NS4b was shown to completely inhibit IFN signaling (Munoz-Jordan et al., 2003). 
 NS5 is the largest flavivirus nonstructural protein (~103 kDa) and is also multifunctional, 
containing both methyltransferase (MTase) and RNA-dependent RNA polymerase (RdRp) 
activities. The N-terminus of NS5 contains extensive sequence homology to S-adenosyl-
methionine (SAM)-dependent MTases (Koonin, 1993). In vitro studies confirmed the MTase 
activity by demonstrating that a purified MTase domain of NS5 could transfer methyl groups 
from SAM to RNA substrates (Egloff et al., 2002). Mutagenesis studies showed that the MTase 
activity was essential for flavivirus replication (Hanley et al., 2002). The RdRp of flaviviruses is 
structurally similar to the RdRps of many other positive-strand RNA viruses (Brinton, 2008; 
Koonin, 1991; Malet et al., 2007; Rice et al., 1985). Mutating amino acids in the highly 
conserved GDD motif of the NS5 RdRp completely ablates RNA synthesis activity, confirming 
the requirement of an intact RdRp domain for viral RNA replication (Kim et al., 2007). Other 
functions have been identified for NS5 in addition to the MTase and RdRp activities. NS5 
contains two nuclear localization signals and has been reported to localize NS5 to the nucleus of 
infected cells depending on its phosphorylation status (Pryor et al., 2007). However, NS5 nuclear 
localization has been shown to vary depending on cell type and virus strain. The mechanism 
controlling NS5’s nuclear localization is unknown but it has been suggested to be involved in 
regulating virus production as well as in mediating the antiviral response to infection by 
regulating IL-8 production (Pryor et al., 2007). Similar to the NS2a, NS4a and NS4b, NS5 was 
also shown to interfere with IFN signaling by binding to the intracellular side of IFN receptor 
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complexes and inhibit the phosphorylation of downstream effector molecules, such as STAT1 
(Best et al., 2005). 
 
Host Genetic Resistance/Susceptibility to Virus-Induced Disease 
 Viruses are intracellular pathogens that must intimately interact with a host cell to 
replicate. This interaction between host and virus is typically parasitic since viruses use host cell 
machinery for synthesis of their products. This relationship is usually detrimental to the host 
when a virus first infects a previously uninfected species. Viruses typically co-evolve with their 
host over time and it is likely that many of the host species populations currently resistant to a 
particular virus infection were selected due to virus-induced morbidity or mortality over time. 
The interactions between host and virus are complex, commonly involving both the innate and 
adaptive immune responses. However, resistance or susceptibility to virus-induced diseases can 
sometimes be controlled by a single gene. There have been approximately 30 examples of this 
phenomenon identified to occur naturally in mice and a few identified in humans (Lee et al., 
2003). Resistance genes are first identified when individuals of a given host species vary in their 
response to infection with a single virus or members of a virus family. Mapping analyses are 
subsequently used to identify the chromosome and then the gene(s) associated with the disease 
response phenotype. There are three main stages of a virus infection at which host resistance 
mechanisms have been shown to function: entry of viruses, intracellular stages of virus 
replication, or recognition and destruction of infected cells by immune cells (Lee et al., 2003). 
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Genetic Resistance due to Blocking Viral Entry 
 Host resistance to virus-induced disease is most commonly observed to occur at the stage 
of virus entry into the cell and defines viral tropism. Examples of viruses for which this has been 
shown to be the case are mouse hepatitis virus (MHV) and human immunodeficiency virus 
(HIV) (Lee et al., 2003). Disease resistance to MHV is conferred by variation in Caecam1, the 
MHV receptor. CEACAM1a is expressed in susceptible BALB/c mice while CAECAM1b is 
expressed in resistant SJL/J mice (Tan et al., 2002). Differences in susceptibility were 
determined to be due to a dramatic difference in MHV binding to these two receptors due to 
substitutions at six residues in an exposed loop of the amino-terminal immunoglobulin-like 
domain where the MHV spike proteins bind (Boyle et al., 1987; Dveksler et al., 1991; Ohtsuka et 
al., 1996; Rao et al., 1997). An example of genetic resistance to virus-induced disease in humans 
was observed during HIV-1 virus infections. Disease resistance is conferred in a subset of 
individuals that express a 32 bp deletion in their CCR5 gene. CCR5 is a co-receptor for M-tropic 
HIV-1 viruses (Berger et al., 1999; Dean et al., 1996; Liu et al., 1996; Samson et al., 1996; 
Zimmerman et al., 1997). Individuals homozygous for this deletion are completely resistant to 
M-tropic HIV-1 infections while heterozygous individuals display delayed progression to the 
onset of AIDS (Berger et al., 1999; Dean et al., 1996). 
 
Genetic Resistance due to Intracellular Effectors 
 Other host genetic resistance mechanisms are mediated intracellularly during viral 
infections. Viruses that are affected by this type of genetic resistance include orthomyxoviruses 
(i.e. influenza A virus and Thogoto virus), vesicular stomatitis virus (VSV), murine leukemia 
virus and members of the genus Flavivirus (Lee et al., 2003). During influenza A virus 
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infections, disease resistance in A2G mice is mediated by the product of the Mx1 dominant allele 
(Haller and Kochs, 2002; Kolb et al., 1992). Susceptible mice, such as CBA/J and BALB/c, do 
not express a functional Mx1 protein due to either a non-sense mutation or a large deletion 
within the allele, respectively (Staeheli et al., 1988). The Mx1 protein is classified as a GTPase, 
homologous to dynamin proteins and is localized within the cell nucleus. It was suggested that 
the Mx1 protein of mice confers resistance to influenza A virus infections by binding the viral 
polymerase and sequestering it to promyelocytic leukemia protein nuclear bodies, thereby 
inhibiting replication of the virus (Geoffroy and Chelbi-Alix, 2011; Haller and Kochs, 2002; 
Stranden et al., 1993). Mice also express an Mx2 protein that is localized to the cytoplasm. This 
protein has been shown to inhibit the replication of viruses such as Thogoto virus (Haller and 
Kochs, 2002). Mx2 proteins interact with Thogoto virus nucleocapsid proteins and prevent their 
translocation into the nucleus which is required for virus replication (Haller and Kochs, 2002). 
The human genome encodes MxA and MxB proteins. Only the MxA protein has been defined as 
having antiviral activity (Haller and Kochs, 2002). In contrast to the mouse Mx1 and Mx2 
proteins that function in separate compartments of the cell, the antiviral activity of human MxA 
functions regardless of the intracellular location and affects numerous other viruses (Haller and 
Kochs, 2002). 
Some inbred mouse strains show differential susceptibility to flavivirus-induced disease 
(Perelygin et al., 2002; Urosevic et al., 1999; Webster and Johnson, 1941). It was shown that an 
allele of a single gene, Flv, conferred differential susceptibility specific to flavivirus infection in 
mice and that resistance is inherited as a dominant Mendelian trait (Groschel and Koprowski, 
1965; Sabin, 1952; Sangster et al., 1993; Sangster and Shellam, 1986). A positional cloning 
approach identified Oas1b as the Flv
r
 gene (Perelygin et al., 2002). When the resistant allele, 
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Flv
r
, was subsequently "knocked in" to a susceptible mouse strain replacing the susceptible 
allele, Flv
s
, the mice generated displayed the flavivirus resistance phenotype (Scherbik et al., 
2007a). These results proved that resistance/susceptibility to flavivirus-induced disease is 
mediated by a single gene.  
OAS proteins are upregulated by interferons that are produced in response to a viral 
stimulus (Sarkar and Sen, 2004). Typically, the antiviral activity of OAS proteins is mediated by 
the recognition of viral dsRNA during infection, which activates the OAS proteins to synthesize 
2′-5′ linked oligo As (2-5 As) from ATP. The 2-5 As then activate latent RNase L to degrade 
viral or cellular ssRNA, thereby inhibiting infection (Figure 1.3). Eight duplicated copies of the 
Oas1 gene exist in mice (Oas1a-h) and are encoded in a 210 kb genomic region on chromosome 
5; however, only Oas1a and Oas1g are functional synthetases (Kakuta et al., 2002). A full-length 
Oas1b protein is expressed by the Flv
r
 allele in resistant mice, while a truncated Oas1b protein is 
expressed in susceptible mouse strains from the Flv
s
 allele (Figure 1.4). The truncated form of 
Oas1b (Oas1bt) is the result of a premature stop codon produced by a C820T transition within 
the fourth exon, yielding a protein that is 30% shorter (Perelygin et al., 2002). Both the full-
length and truncated Oas1b proteins have a four amino acid deletion in their N-terminal P-loop 
motif as well as a deletion in their C-terminal CFK motif. The CFK motif and the P-loop motif 
are critical for 2-5 OAS activity and the CFK motif is essential for multimerization. 
 
Genetic Resistance due to Recognition and Destruction by Immune Cells 
 Alleles that confer disease resistance are sometimes involved in the recognition and 
removal of the virus by immune cells. Some examples of viruses that are susceptible to these 
alleles include Friend leukemia virus and murine cytomegalovirus (MCMV) (Britt and Chesebro, 
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1980; Farrell et al., 1997; Lee et al., 2003). In the case of MCMV, resistance is observed in 
C57BL/6 mice and is mediated by the product of the Cmv1
r
 allele, which encodes the Ly49H 
activating receptor expressed by natural killer (NK) cells that can recognize the MCMV m157 
antigen expressed on the surface of infected cells and mediate their killing (Brown et al., 2001; 
Daniels et al., 2001; Lee et al., 2001). This is in contrast to susceptible DBA/2 mice that possess 
the Cmv1
s
 allele that does not encode the Ly49H receptor, but instead encodes the Ly49I 
inhibitory receptor on NK cells that also recognizes and binds to m157 but does not result in 
infected cell killing by NK cells (Arase et al., 2002). The m157 antigen mimics MHC class I 
molecules and are recognized by Ly49I leading to inhibitory signaling that downregulates MHC 
class I expression in infected cells (Adams et al., 2007).  Due to these differences, resistant mice 
are able to control the infection by removing the MCMV-infected cells through NK cell 
mediated killing, whereas susceptible mice are unable to efficiently activate their NK cell 
response to stop the MCMV infection, resulting in higher viral titers in infected mouse tissues 
(Scalzo et al., 1990). 
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Figure 1.3. Schematic representation of the OAS-RNase L innate immune response 
pathway. (A) During RNA virus infections, (B) dsRNA is produced that is sensed by OAS 
proteins. (C) Upon recognition of dsRNA, these OAS proteins synthesize short 2′ – 5′ linked 
oligo As from ATP. (D) The oligo As activate latent RNase L, which can then degrade cellular 
and viral RNAs, (E) thereby blocking cell and viral translation. 
Modified figure and legend adapted from (Silverman, 2007). 
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Figure 1.4. Schematic representation of full lenth and truncated Oas1b. Full length Oas1b is 
generated from the Flv
r
 resistance allele while truncated Oas1b (Oas1bt) is generated from the 
Flv
s
 susceptibility allele. Oas1bt is ~30% shorter due to a premature stop codon within the 4
th
 
exon. Image adapted with permission from Dr. Husni Elbahesh. 
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Stress Granules 
Translation initiation starts with the formation of the 43S complex of the small 40S 
ribosome subunit, eIF2-GTP-tRNAi
Met
, and eIF3 (Pestova et al., 2001). The 43S subunit then 
associates with other initiation factors (i.e. eIF4F, eIF4A, eIF4B, eIF1A and poly A binding 
protein) and scans the 5′ UTR of the mRNA until it locates the initiator codon and forms the 48S 
pre-initiation complex (Anderson and Kedersha, 2002b). eIF2-bound GTP in the 48S pre-
initiation complex is then hydrolyzed by eIF5, resulting in the release of some initiation factors 
and allowing the binding of the large 60S ribosomal subunit to produce the complete 80S 
ribosome (Anderson and Kedersha, 2002b; Pestova et al., 2001). The 80S ribosome can then 
continue the translation of the nascent protein by moving down the mRNA and allowing other 
80S ribosomes to form at the beginning of the mRNA, creating a polysome. Environmental 
stresses such as oxidation, UV irradiation, heat, and viral infection lead to the transient formation 
of discrete cytoplasmic foci known as stress granules (SGs) (Anderson and Kedersha, 2002a, 
2006, 2007, 2008; Emara and Brinton, 2007; Gilks et al., 2004; Kedersha and Anderson, 2002; 
Kedersha et al., 2002; Kedersha et al., 1999). Stress granules were first discovered in chicken 
embryo fibroblast cells maintained at 45ºC (Collier and Schlesinger, 1986). In response to stress, 
the alpha subunit of eIF2 (eIF2α) is phosphorylated by one of four eIF2α kinases, protein kinase 
R (PKR), PKR-related endoplasmic reticulum localized kinase (PERK), general control 
nonrepressed 2 kinase (GCN2), or heme-regulated inhibitor kinase (HRI) (Anderson and 
Kedersha, 2002a, 2008). Phosphorylation of the alpha subunit of the eIF2αβγ ternary complex 
converts it to a competitive inhibitor of eIF2B and renders it unable to load initiator tRNAi
Met
 to 
the ribosome for the initiation of protein synthesis. The decreased amounts of available eIF2-
GTP-tRNAi
Met 
then allows the binding of RNA-binding proteins such as T cell intracellular 
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antigen 1 (TIA-1), TIA1-related (TIAR) or Ras GTPase-activating protein-binding protein 
(G3BP) to 48S pre-initiation complexes (Gilks et al., 2004; Kedersha and Anderson, 2002). 
These proteins can self aggregate to form SGs. Binding of these proteins to 48S pre-initiation 
complexes leads to the stalling of mRNA translation (translational arrest) and results in 
dissociation of the polysomes through run off of ribosomes (Figure 1.5A-C) (Anderson and 
Kedersha, 2002a). However, global translation is not completely silenced since the translation of 
stress-response proteins including the heat shock proteins still occurs (Anderson and Kedersha, 
2008; Kedersha et al., 2002). Other components of SGs include translation initiation factors 
(eIF4E, eIF3, eIF4A, and eIFG), PABP, and other RNA-binding proteins involved in mRNA 
splicing, transcription, signaling and development (Anderson and Kedersha, 2007, 2008). In two 
recent reviews by Anderson et al. (Anderson and Kedersha, 2006, 2008), lists of proteins shown 
to co-localize to SGs by fluorescent microscopy are provided (Anderson and Kedersha, 2006, 
2008). It is thought that numerous species of SGs exist with varying protein components and that 
SGs are dynamic, rather than static in nature (Kedersha et al., 2000). Messenger RNAs 
sequestered in SGs can subsequently either be released for reinitiation of translation (Figure 
1.5D) or moved to processing bodies (PBs) for degradation (Figure 1.5E) (Anderson and 
Kedersha, 2006, 2007; Beckham et al., 2007; Sheth and Parker, 2003).  
  
Virus-Induced Stress Granule Formation 
 Virus infections can induce SG formation; however, not all virus infections induce the 
formation of SGs. Formation of SGs during viral infections is typically mediated by PKR, which 
senses double-stranded viral RNA, and/or by PERK, which is activated in response to the 
accumulation of unfolded proteins in the ER. Many types of viruses induce the formation of SGs 
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Figure 1.5. Canonical pathway for the formation of stress granules. (A-C) Once 48S pre-
initiation complexes stall, the polysomes begin to dissociate through ribosome run off and the 
stalled pre-initiation complexes are then bound to SG-nucleating proteins such as TIA-1 and 
TIAR forming SGs. (D) After recovery from stress, mRNAs bound in these SGs can reinitiate 
translation. (E) If stress is not relieved, the mRNAs in SGs can be sent to processing bodies for 
degradation. Modified figure and legend adapted from (Anderson and Kedersha, 2002a). 
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but some also actively suppress SG formation (Ariumi et al., 2011; Dauber et al., 2011; 
Dougherty et al., 2011; Hanley et al., 2010; Khong and Jan, 2011; Legros et al., 2011; Lindquist 
et al., 2011a; Lindquist et al., 2011b; McInerney et al., 2005; Montero et al., 2008; Piotrowska et 
al., 2010; Querec et al., 2009; Rojas et al., 2010; Simpson-Holley et al., 2011; White et al., 
2007). For example, infections with Semliki Forest virus (SFV) and some strains of reoviruses 
shut down host translation and induce the formation of SGs. SGs form in SFV-infected cells but 
SFV encodes a translation enhancer that works downstream of eIF2α phosphorylation and is 
involved in disassembling SGs located in close proximity to the viral positive-sense genome 
RNA, thus allowing the translation of SFV viral proteins but not most host proteins (McInerney 
et al., 2005). Reovirus c8 and c87 strain infections inhibit host protein translation, whereas 
infections by the Dearing reovirus stain do not. The inhibition of host protein translation during 
c8 and c87 reovirus infections induces the formation of SGs but allows the selective translation 
of reovirus proteins (Smith et al., 2006). The precise mechanism by which these reovirus strains 
selectively translate viral proteins in the presence of SGs is unknown; however, it was reported 
that the expression of ATF4, a transcription factor important for cellular recovery from stress, 
was required for the increased replication efficiency of these strains (Smith et al., 2006).  
Poliovirus infections have also been shown to induce the formation of SGs early after infection 
(Dougherty et al., 2011; Mazroui et al., 2006; Piotrowska et al., 2010; White et al., 2007). As the 
infection continues, SGs disassemble due to the cleavage of the SG protein G3BP by the viral 3C 
protease (White et al., 2007). However, recent studies have shown that although G3BP-positive 
SGs disassembled in poliovirus-infected cells, TIA-1-containing SGs did not disassemble 
(Piotrowska et al., 2010). Recently, infection of BHK cells with the highly attenuated yellow 
fever virus vaccine, YF-17D, was reported to efficiently induce the formation of SGs (Querec et 
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al., 2009). This is in contrast to previous studies done in our lab showing that infections by other 
members of the genus Flavivirus, WNV and dengue virus, did not induce SGs and inhibited the 
formation of SGs induced by oxidative stress (Emara and Brinton, 2007).  
Although rotavirus infections have been reported to induce the phosphorylation of eIF2α 
at early times after infection which leads to host cell shut off via the activation of PKR, SGs do 
not form in these infected cells (Montero et al., 2008; Rojas et al., 2010). The mechanism by 
which rotavirus infections prevent SG formation in infected cells is currently unknown, but 
studies have shown that infected cells dramatically relocalize host SG proteins to different 
compartments (i.e. poly A binding protein relocates from the cytoplasm to the nucleus) 
suggesting the possibility that these proteins are being used for the benefit of virus replication 
(Montero et al., 2008). Human T cell leukemia virus (HTLV)-1 infections have also been shown 
to inhibit the formation of SGs (Legros et al., 2011). The HTLV-1 Tax protein was initially 
described as a viral oncoprotein, but has also been shown to translocate from the nucleus to the 
cytoplasm during different stresses of infected cells (Gatza and Marriott, 2006; Suzuki et al., 
1996). Studies showed that cytoplasmic Tax was capable of inhibiting the formation of SGs 
during infection through its interaction with histone deacytelase 6 (HDAC6) (Legros et al., 
2011). The exact mechanism by which the Tax-HDAC6 interaction inhibits SG formation is 
currently unknown but this study represents the first example of a virally encoded protein 
responsible for specifically inhibiting SG formation in infected cells. Future studies will likely 
identify other unique pathways utilized by viruses to inhibit SG formation during infection. 
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GOALS OF THIS DISSERTATION 
 
Specific Aim 1: To identify and characterize unique cellular binding partners of Oas1b and 
to analyze the involvement of selected Oas1b interaction partners in the West Nile virus 
infection cycle. 
Viruses use host cell proteins to facilitate their replication in infected cells. Resistance 
specific to flavivirus-induced disease in mice is conferred by the Flv gene, which was identified 
as the enzymatically inactive 2'-5' oligoadenylate synthetase 1b (Oas1b) (Scherbik et al., 2007a). 
The only known antiviral activity associated with Oas proteins is through the activation of 
RNaseL; however, Oas1b was shown to be a non-functional synthetase, suggesting that Oas1b 
mediates its antiflaviviral activity through an OAS-RNaseL-independent pathway. Experiments 
were proposed to identify cellular protein(s) interaction partners of Oas1b and to analyze the 
function of those candidate proteins in the WNV replication cycle to gain insights about the 
mechanism by which Oas1b specifically reduces the efficiency of flavivirus replication 
 
Specific Aim 2: To analyze the formation of virus-induced stress granules during infection 
of BHK cells with a WNV lineage 2-based infectious clone. 
Previous work in the lab showed that infections with the natural WNV strain Eg101 do 
not induce the formation of SGs in BHK cells (Emara and Brinton, 2007). However, recent 
studies showed that infections with a chimeric WNV lineage 2/1 infectious clone (W956IC) did 
induce the formation of SGs. Studies were performed to identify the kinase responsible for SG 
formation in W956IC-infected cells and to analyze the mechanism of differential SG formation 
by infections with natural WNV strains and W956IC. 
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CHAPTER 2 
 
Specific Aim 1: To identify and characterize unique cellular binding partners of Oas1b and 
to analyze the involvement of selected Oas1b interaction partners in the West Nile virus 
infection cycle. 
INTRODUCTION 
The genus Flavivirus consists of about 60 viruses and includes human pathogens such as  
dengue virus, yellow fever virus, Japanese encephalitis virus, and West Nile virus (WNV) 
(Lindenbach, 2007). West Nile virus was first isolated in Uganda in 1937 and has been endemic 
in Africa, southern Europe, Australia, and southern Asia (Brinton, 2002). Recently, it emerged in 
the United States with over 23,000 cases reported as of late 2006 (Brinton, 2008; Sejvar, 2007). 
WNV is arthropod-borne and its transmission cycle in nature is usually between Culex mosquito 
species and birds, but virus transmission to horses and humans by mosquitoes occurs 
occasionally (Brinton, 2002). WNV infection of humans is usually asymptomatic but can 
sometimes result in mild disease with symptoms such as fever, headache, body rash, muscle 
fatigue, and disorientation (Brinton, 2002). About 1 in 150, or fewer, infected individuals 
develop more severe diseases such as encephalitis, meningoencephalitis, paralysis,  
poliomyelitis-like paralysis or hepatitis (Brinton, 2002).   
The flavivirus genome is a positive-sense, single-stranded RNA with a capped 5' end but 
no 3' poly (A) tail. These features are unique among mammalian positive-sense RNA viruses 
(Brinton, 2002). The 11 kb flavivirus genome encodes one open reading frame that contains 
three N-terminal viral structural proteins, capsid (C), membrane (prM, M), and envelope (E), 
followed by seven nonstructural proteins, NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5 
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(Brinton, 2002). The ten mature viral proteins are generated by proteolytic processing of the 
polyprotein by viral and cellular proteases (Brinton, 2002). The majority of the non-structural 
proteins are multi-functional and all seven appear to be involved in viral RNA synthesis 
(Brinton, 2002; Mackenzie et al., 1996).   
The 2'-5' oligoadenylate synthetase (2-5 OAS)/RNase L pathway is one of the innate host 
defenses against viral infections. OAS gene expression is up-regulated by interferons produced 
by cells in response to a viral infection (Sarkar and Sen, 2004). Viral double-stranded RNA 
(dsRNA) activates OAS causing it to polymerize adenosine triphosphate (ATP) into short 2'-5'-
linked oligomers (2-5A) (Justesen et al., 2000). These oligomers then bind to and activate latent 
endoribonuclease L (RNase L) that is constitutively expressed in cells.  Activated RNase L 
cleaves viral and cellular single-stranded RNAs, thereby reducing viral translation (Kakuta et al., 
2002). Eight duplicated copies of the OAS1 gene (Oas1a-h) are clustered within a 210 kb 
genomic region on mouse chromosome 5 (Kakuta et al., 2002). Previous breeding studies with 
mice displaying differential susceptibility to flavivirus-induced disease showed that the alleles of 
a single Mendelian dominant gene, Flv, controlled this phenotype (Webster and Clow, 1936; 
Webster and Johnson, 1941). Oas1b was identified by a positional cloning strategy as the Flv 
gene (Perelygin et al., 2002). A full-length Oas1b protein is expressed by the Flv
r
 allele in 
resistant mice, while a truncated Oas1b (Oas1bt) protein is expressed from the Flv
s
 allele in 
susceptible mice. The resistant allele, Flv
r
, was "knocked in" to a susceptible mouse strain, 
C57BL/6 (B6), replacing the susceptible allele, Flv
s
, to generate C57BL/6-Oas1bKI (KI) mice 
that display the flavivirus resistance phenotype (Scherbik et al., 2007a). Among the eight Oas1 
genes in mice only Oas1a and Oas1g have been reported to be functional synthetases (Elbahesh 
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et al., 2011a; Kakuta et al., 2002). Therefore, Oas1b does not mediate its antiviral activity 
through the canonical OAS-RNase L pathway (Elbahesh et al., 2011a; Scherbik et al., 2006). 
As one means of gaining insights into the mechanism by which Oas1b specifically 
reduces the efficiency of flavivirus replication, cellular protein interaction partners of Oas1b 
were identified and their involvement in the Oas1b-mediated flavivirus resistance mechanism 
was analyzed. Results from the current study identified peptides from ORP1L and ABCF3 as 
Oas1b interaction partners in a yeast two-hybrid analysis. These interactions were confirmed by 
in vitro yeast co-transformation and co-immunoprecipitation assays, as well as by 
immunoprecipitation studies in mammalian cells using full length proteins. RNAi knockdown of 
ORP1L resulted in decreased replication of the flavivirus WNV as well as of other RNA viruses 
and this effect did not require the presence of Oas1b. Knockdown of ORP1L was recently 
reported to cause increased endosomal movement (Vihervaara et al., 2011) and this could 
explain the observed effect on the replication of multiple viruses that enter cells by endocytosis. 
Knockdown of ABCF3 increased WNV replication but not Sindbis virus replication and this 
effect was only observed in Oas1b-expressing cells. The results provide new insights about the 
Oas1b-mediated flavivirus resistance mechanism. 
 
RESULTS 
Identification of putative Oas1b binding partners in a yeast two-hybrid screen 
Although Oas1b was identified as the only gene needed to confer resistance to flavivirus-
induced disease in mice (Scherbik et al., 2007a), it was shown to mediate its flavivirus-specific 
antiviral activity by an RNase L-independent mechanism (Elbahesh et al., 2011a; Scherbik et al., 
2006). A yeast two-hybrid screen was used to identify candidate cell protein Oas1b binding 
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partners that might participate in the Oas1b-mediated anti-flaviviral mechanism. In initial 
experiments, a pre-transformed Mouse Brain cDNA library was screened as described in 
Materials and Methods against a full length Oas1b bait; however, no viable yeast colonies were 
detected on the selection plates. Yeast two-hybrid screens are unable to detect interactions with 
proteins containing a transmembrane domain that tethers them to cytoplasmic membranes 
preventing their translocation to the nucleus to act as transcription factors (Iyer et al., 2005). 
None of the members of the OAS family so far analyzed have previously been reported to have a 
transmembrane domain. However, analysis of the Oas1b sequence using the PredictProtein 
software (www.predictprotein.org) predicted a short transmembrane domain starting 23 amino 
acids from the C-terminus (Figure 2.1A). To determine whether the predicted transmembrane 
domain of Oas1b was able to tether it to a cytoplasmic membrane, a vector expressing a GST-
tagged full length Oas1b protein was transiently transfected into BHK cells and the localization 
of the protein was detected by confocal microscopy. Oas1b colocalized with the endoplasmic 
reticulum (ER) marker calnexin, but not with the mitochondrial marker CoxIV (Figure 2.1B). 
Oas1b was shown to remain localized to the ER after WNV infection of these cells (Figure 
2.1B). In contrast, transient expression of a GST-tagged truncated Oas1b (GST-Oas1bt) or a 
GST  tag  alone  resulted  in  a  diffuse  protein  distribution  throughout  the  cell  with  no  ER 
colocalization (Figure 2.1B). These results confirmed the presence of a transmembrane tail on 
the full length Oas1b protein that anchors Oas1b to the ER membrane. The sequence of the 
Oas1b transmembrane domain was BLASTed against the GenBank database but no matches 
were found. The origin of this domain and the mechanism by which it was acquired by Oas1b are 
currently not known. 
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Figure 2.1. Full length Oas1b contains a transmembrane domain that localizes it to the ER 
membrane. (A) The full length Oas1b protein expressed in resistant cells is predicted to contain 
a C-terminal transmembrane domain. The Oas1bΔTM truncation mutant lacks the C-terminal 
transmembrane tail.. The truncated Oas1b (Oas1bt) expressed in susceptible cells is generated by 
a premature stop codon in exon 4. (B) Plasmids expressing GST, GST-Oas1bt, or GST-Oas1b 
were transiently transfected into BHK cells. Twenty-four hr later, cells were either mock-
infected or infected with WNV Eg101 (MOI of 5) and at 24 hr after infection cells were fixed, 
permeabilized, incubated with the indicated antibodies and analyzed by confocal microscopy. 
Anti-GST antibody (green) detected GST-tagged Oas1b, anti-calnexin antibody (red) detected 
ER, anti-CoxIV antibody (red) detected mitochondria and Hoechst (blue) stained nuclei. 
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A C-terminally truncated Oas1b mutant consisting of amino acids 1-353 of full length 
Oas1b and referred to as Oas1bΔTM (Figure 2.1A) was next cloned into the yeast two-hybrid 
bait vector pGBKT7. When the Oas1bΔTM protein was used as the bait in a two-hybrid assay 
with the Mouse Brain cDNA library, 23 unique candidate partner peptides were identified.  
Interaction between each of these peptides and Oas1bΔTM was subsequently tested with yeast 
co-transformation assays as described in Materials and Methods. Growth of colonies on double 
selection media indicated that cells were co-transformed with both the bait and prey plasmids 
and growth of colonies on the quadruple selection media indicated that the two peptides 
interacted in yeast. Of the 23 putative peptide partners, an interaction with Oas1b was confirmed 
for only eight by yeast co-transformation assay on quadruple dropout selection media (Table 1). 
The protein origin of each of the putative peptide partners was predicted using a BLAST 
analysis. 
 
Co-immunoprecipitation of putative binding partners and Oas1b 
Since yeast two-hybrid analyses can produce false-positive results, in vitro co-
immunoprecipitation assays were used to further confirm that the putative peptide partners 
interacted with Oas1bΔTM. Oas1bΔTM and each of the putative partners was in vitro 
transcribed and translated in the presence of 
35
S-labeled methionine. Oas1bΔTM and one of the 
putative partners were then incubated together for 1 hr at RT and interaction was assessed by co-
immunoprecipitation as described in Materials and Methods. The in vitro translated Oas1bΔTM 
had an N-terminal c-Myc tag and each of the putative partners had an N-terminal HA tag. 
Oas1bΔTM co-immunoprecipitated with the oxysterol binding protein related protein 1L 
(ORP1L) peptide as well as with the ATP binding cassette protein 3, subfamily F (ABCF3)  
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       Table 1. Oas1bΔTM Yeast Two-Hybrid Analysis Results. 
 
 
 
 
            
           *The length of the peptide in each clone is indicated in parentheses. 
  
Clone 
No.
16-1 
(169 aa)
27-6-4 
(214 aa)
42-3-5 
(81 aa)
49-2-2 
(32 aa)
68a-2-3 
(253 aa)
84-1-2 
(136 aa)
113-1 
(223 aa)
163-1-2 
(263 aa)
Nucleosome Assembly Protein 1-like 2
Cytochrome C Oxidase Assembly Protein
Euchromatic Histone Lysine N-Methyltransferase 2
Putative Protein Partner
OSBP-Related Protein 1L (Orp1L)
Eukaryotic Elongation Factor 1a
ATP-Binding Cassette subfamily f, member 3 (Abcf3)
Heterogenous Nuclear Ribonucleoprotein
Microtubule-associated Protein 1A
31 
 
 
peptide (Figure 2.2A and B, respectively). None of the other putative peptide partners interacted 
with Oas1bΔTM in vitro. To determine whether these two peptides could also interact with 
Oas1bt, co-immunoprecipitation experiments were performed with in vitro synthesized, N-
terminal c-Myc tagged Oas1bt and each of the two partners. The ORP1L peptide did not co-
immunoprecipitate with Oas1bt (Figure 2.2C), suggesting that the interaction between this 
peptide and Oas1bΔTM occurs in a region located after the premature stop codon of Oas1bt and 
before the transmembrane domain of Oas1b.  In contrast, the ABCF3 peptide did co-
immunoprecipitate with Oas1bt (Figure 2.2D), indicating that this peptide interacts with both 
Oas1b and Oas1bt in a region upstream of the premature stop codon of Oas1bt. Also, a yeast 
two-hybrid screen using Oas1a as bait identified ABCF3 to interact, suggesting that ABCF3 
interacts with multiple mouse OAS proteins and possibly human OAS proteins and isoforms. 
Because the peptides used in the previous experiments represented only a portion of each 
of the putative interaction partners and the interactions were detected either in vitro or in yeast 
cells, the results could not predict whether the whole proteins would interact with full length 
Oas1b. The interaction of Oas1b and a full length partner was next tested in mammalian cells by 
co-immunoprecipitation. Oas1b is one of eight duplicated Oas1 genes in mouse cells (Perelygin 
et al., 2002). Due to the high degree of homology between the Oas1 proteins, it has not been 
possible  to  make  an  antibody  that  can  specifically  detect  individual  mouse  Oas1  proteins. 
Therefore, a tagged Oas1b protein was transiently expressed. He MEFs were stably transfected 
with both 3xFLAG-tagged full length Oas1b and V5-tagged ORP1L (He-Oas1b/Orp1L), as 
described in the Materials and Methods. The in vivo interaction between Oas1b and either 
ORP1L or ABCF3 was assessed by co-immunoprecipitation as described in the Materials and 
Methods.  Prior  to  lysis,  cells  were  treated  with  DSP,  a  thiol-reversible  chemical  protein- 
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Figure 2.2. In vitro co-immunoprecipitation of Oas1bΔTM and putative partner peptides 
16-1 (Orp1L) and 42-3-5 (Abcf3). Wheat germ extract was used to in vitro transcribe and 
translate Oas1bΔTM or Oas1bt and putative peptide clones in the presence of [35S]-methionine. 
One of the Oas1b proteins and a candidate peptide were mixed and immunoprecipitated. 
Immunoprecipitated protein complexes were resolved by SDS-PAGE and detected by 
autoradiography. (A) 
35
S-labeled c-Myc-tagged Oas1bΔTM and HA-16-1 (Orp1L) peptides were 
immunoprecipitated with anti-HA antibody. (B) 
35
S-labeled c-Myc-tagged Oas1bΔTM and HA-
42-3-5 (Abcf3) peptides were immunoprecipitated with anti-HA antibody.  (C) 
35
S-labeled c-
Myc-tagged Oas1bt and HA-16-1 (Orp1L) peptides were immunoprecipitated with anti-HA 
antibody. (D) 
35
S-labeled c-Myc-tagged Oas1bt and HA-42-3-5 (Abcf3) peptides were 
immunoprecipitated with anti-HA antibody. Lys-lysates; C-Control (agarose beads alone or anti-
IgG antibody); α-HA-anti-HA antibody.  
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rosslinker, to stabilize transient or weak interactions. Antibody to the Oas1b FLAG tag 
immunoprecipitated both ORP1L and ABCF3 (Figure 2.3). The interaction of these proteins was 
also analyzed in WNV-infected cells. He-Oas1b/Orp1L cells were infected with WNV Eg101 at 
a MOI of 1 and harvested at 24 hr after infection. Both ORP1L and ABCF3 were 
immunoprecipitated by antibody to the Oas1b FLAG tag in infected cells (Figure 2.3). In 
contrast, anti-FLAG antibody did not immunoprecipitate WNV NS3 (Figure 2.3), suggesting that 
Oas1b does not interact directly with WNV replication complexes and that the co-
immunoprecipitation results obtained were specific. 
 
The effect of reducing ORP1L protein levels on virus infections 
The previous experiments showed that ORP1L interacts with Oas1b in vivo. It was 
hypothesized that if ORP1L is an essential component of the Oas1b-mediated anti-flavivirus 
mechanism, then the WNV yield, as well as viral RNA (vRNA) and protein levels would 
increase when ORP1L is knocked down.  ORP1L protein expression was reduced by stable 
expression of an ORP1L-specific shRNA in KI MEFs. Clonal cell lines were selected as 
described in the Materials and Methods. The KI shOrp1L-6 clonal cell line had the lowest 
ORP1L protein levels compared to the KI shCont-7 non-specific control cell line of the 19 lines 
tested (Figure 2.4A). KI shCont-7 and KI shOrp1L-6 cells were infected with WNV Eg101 at a 
MOI of 1 and clarified culture fluid, total cell RNA, and cell lysates were harvested at the 
indicated times after infection from duplicate wells. Virus yields were  measured by plaque assay 
on BHK cells and the yields produced by KI shOrp1L-6 cells at 24 to 48 hr after infection were 
reduced compared to those from KI shCont-7 cells (Figure 2.4B). Intracellular viral RNA was 
detected by real time qRT-PCR using WNV NS1 region-specific primers and probe. Reduced 
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Figure 2.3. Mammalian cell co-immunoprecipitation of V5-tagged Orp1L and endogenous 
Abcf3 with FLAG-tagged Oas1b. He-Oas1b/Orp1L MEFs that express N-terminally FLAG-
tagged Oas1b and C-terminally V5-tagged Orp1L were either mock-infected or infected with 
WNV Eg101 (MOI of 1), treated with 0.5 mM DSP for 30 min on ice to stabilize transient or 
weak interactions. The reaction was quenched with 50 mM Tris pH 7.5 for 15 min on ice, cells 
were harvested at 24 hr in lysis buffer. Lysates were immunoprecipitated with either control 
antibody or anti-FLAG antibody, as indicated. Western blotting was done to detect Orp1L (anti-
V5 antibody), Abcf3 (anti-Abcf3 antibody), NS3(anti-NS3 antibody), and Oas1b protein (anti-
FLAG antibody).  Lys-lysates; C-Control (anti-IgG antibody-conjugated agarose); FLAG-anti-
FLAG antibody-conjugated agarose. 
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viral RNA (vRNA) levels in KI shOrp1L-6 cells were observed from 24 to 48 hr after infection 
compared to those in KI shCont-7 cells (Figure 2.4C). Western blotting of the WNV NS3 protein 
showed that viral protein levels were also reduced in KI shOrp1L-6 cells compared to KI 
shCont-7 at 24 to 48 hr after infection (Figure 2.4D). To confirm that the results observed were 
due to the reduction of ORP1L protein and not to a decrease in cell viability, an MTT assay was 
performed. Approximately 15% cell death was observed at 48 hr after Eg101 infection in both 
cell lines compared to mock-infected cells (Figure 2.4E). It was noted that the efficiency of 
ORP1L knockdown by shRNA decreased with time after WNV infection suggesting that the 
RNAi pathway was antagonized in infected cells.  
The antiviral activity of Oas1b is specific to flaviviruses. Therefore, if ORP1L is 
involved in the Oas1b-mediated resistance mechanism its reduction would be unlikely to affect 
an infection with a virus from another family. To test this hypothesis, wildtype B6 and KI MEFs 
were  infected with a member of another positive strand RNA virus  family, the alpha togavirus 
Sindbis virus (SinV), at an MOI of 20 and clarified culture fluid and infected cell lysates were 
harvested at the indicated times after infection from replicate wells. Virus yields and intracellular 
viral protein levels were similar from the two types of cells (Figure 2.5A and B). These results 
confirmed the flavivirus-specificity of Oas1b-mediated resistance. The affect of ORP1L 
knockdown on a SinV infection in Oas1b-expressing cells was next assessed. KI shCont-7 and 
KI shOrp1L-6 cell lines were infected with SinV at an MOI of 20. SinV yields from KI 
shOrp1L-6 MEFs were reduced by ~0.5-1 log compared to those from KI shCont-7 MEFs 
(Figure 2.5C). A reduction was also observed in SinV capsid protein levels in KI shOrp1L-6 
MEFs compared to KI shCont-7 MEFs (Figure 2.5D). A negative effect on the yield of the 
negative strand RNA virus vesicular stomatitis virus (VSV) was also observed (Figure 2.5F). 
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Figure 2.4. The effect of Orp1L knockdown on WNV infection in KI MEFs stably 
expressing shRNAs targeting Orp1L. (A) Western blot analysis of Orp1L protein levels in KI 
shCont-7 and KI shOrp1L-6 MEFs were detected using anti-Orp1L R247 antibody. KI shCont-7 
and KI shOrp1L-6 MEFs were infected with WNV Eg101 at a MOI of 1. (B) Virus yields from 
infected KI shCont-7 and KI shOrp1L-6 MEFs were determined by plaque assay in BHK cells. 
(C) Viral RNA levels were assayed by real time qRT-PCR. (D) Viral protein (NS3) levels were 
measured by Western blotting. (E) KI shCont-7 and KI shOrp1L-6 MEFs were infected with 
WNV Eg101 at a MOI of 1 and analyzed for cell death using a Cell Titer 96® non-radioactive 
cell proliferation assay according to manufacturers protocol. 
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Figure 2.5. The effect of Orp1L knockdown on Sindbis virus and vesicular stomatitis virus 
infections. (A and B) Wildtype B6 (Oas1bt-expressing) and KI (Oas1b-expressing) cells were 
infected with Sindbis virus (SinV) at a MOI of 20. (A) SinV yields from B6 and KI MEFs were 
measured by plaque assay on BHK cells. (B) SinV capsid protein levels in B6 and KI-infected 
MEF lysates were determined by Western blotting. (C and D) KI shCont-7 and KI shOrp1L-6 
cells were infected with SinV at a MOI of 20. (C) SinV yields from infected KI shCont-7 and KI 
shOrp1L-7 MEFs were measured by plaque assay in BHK cells. (D) SinV capsid protein levels 
from infected KI shCont-7 and KI shOrp1L-7 MEFs were determined by Western blotting. (E) 
Wildtype B6 (Oas1bt-expressing) and KI (Oas1b-expressing) cells were infected with Vesicular 
stomatitis virus (VSV) at a MOI of 5. VSV yields from B6 and KI MEFs were measured by 
plaque assay on BHK cells. (F) VSV yields from infected KI shCont-7 and KI shOrp1L-7 MEFs 
were measured by plaque assay in BHK cells. 
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The results suggest that ORP1L may be a proviral host cell protein that is utilized by different 
families of RNA viruses. However, knockdown of ORP1L was previously reported to enhance 
the movement of late endosomes (Vihervaara et al., 2011) and this could negatively affect the 
replication of viruses that enter cells by endocytosis by altering the fusion stage of viral genome 
release.  
 
The effect of reducing ABCF3 protein levels on virus infections 
Since ABCF3 was also shown to interact with Oas1b in vivo, the effect of reducing 
ABCF3 protein levels on WNV infection in KI cells was determined. shRNAs targeting ABCF3 
or a non-specific shRNA control were transduced into KI cells and clonal cell lines were selected 
as described in Materials and Methods. The KI shAbcf3-8 clonal cell line had the greatest 
knockdown efficiency of ABCF3 protein as compared to the KI shCont-7 control cell lines of 21 
lines tested (Figure 2.6A). KI shCont-7 and KI shAbcf3-8 MEFs were infected with WNV 
Eg101 at a MOI of 1 and samples were collected for analysis at the indicated times after 
infection. A slight increase in virus yields from the KI shAbcf3-8 cells were observed at 32 and 
48 hr after infection compared to those from KI shCont-7 cells (Figure 2.6B). An increase in the 
levels of WNV vRNA and NS3 protein was also observed compared to those in KI shCont-7 
cells (Figure 2.6C and D). An MTT assay done on KI shCont-7 and KI shAbcf3-8 cells at 24 and 
48 hr after infection with WNV Eg101 at a MOI of 1 detected about 15% cell death at 48 hr after 
infection in both cell lines compared to mock-infected cells (Figure 2.6E). Similar to that which 
was seen with infection of KI shOrp1L-6 cells, a decrease in the efficiency of ABCF3 
knockdown by shRNA was also observed with time after WNV infection.  
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Figure 2.6. The effect of Abcf3 knockdown on WNV infection in KI MEFs stably 
expressing shRNAs targeting Abcf3. (A) Western blot analysis of Abcf3 protein levels in KI 
shCont-7 and KI shAbcf3-8 MEFs. KI shCont-7 and KI shAbcf3-8 MEFs were infected with 
WNV Eg101 at a MOI of 1. (B) Virus yields from infected KI shCont-7 and KI shAbcf3-8 MEFs 
were determined by plaque assay in BHK cells. (C) Viral RNA levels were assayed by real time 
qRT-PCR. (D) Viral protein (NS3) levels were measured by Western blotting. (E) KI shCont-7 
and KI shAbcf3-8 MEFs were infected with WNV Eg101 at a MOI of 1 and analyzed for cell 
death using a Cell Titer 96® non-radioactive cell proliferation assay according to manufacturers 
protocol. 
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Since the antiviral activity of Oas1b is specific to flaviviruses, the affect on a SinV 
infection of knocking down ABCF3 was also tested. KI shCont-7 and KI shAbcf3-8 MEF 
cultures were infected with SinV at an MOI of 20 and samples were collected as described above  
at the indicated times after infection. SinV yields from KI shAbcf3-8 MEFs were the same as 
those from KI shCont-7 MEFs (Figure 2.7A). Similarly, SinV capsid protein levels did not 
change when ABCF3 proteins were knocked down (Figure 2.7B). VSV infections were also 
tested and virus yield was not shown to be affected by the knockdown of ABCF3 (Figure 2.7C). 
The data indicate that reduction of enhanced ABCF3 is involved in the Oas1b-mediated 
flavivirus-specific antiviral mechanism. 
To test whether the antiviral activity of ABCF3 requires the presence of Oas1b, ABCF3 
expression was knocked down in B6 cells that express Oas1bt. shRNAs targeting either ABCF3 
or a nonspecific shRNA control were transduced into B6 cells and clonal cell lines were selected 
as described in the Materials and Methods. The B6 shAbcf3-8 clonal cell line had the greatest 
reduction of ABCF3 protein levels compared to the B6 shCont-3 control cells of 8 clones tested 
(Figure 2.8A). B6 shCont-3 and B6 shAbcf3-8 MEFs were infected with WNV Eg101 at an MOI 
of 1 and samples were collected as described above at the indicated times after infection. No 
effect on virus yield or vRNA or viral protein levels was detected in either type of cell (Figure 
2.8B-D). These results indicate that the flavivirus-specific, antiviral activity of ABCF3 requires 
the presence of Oas1b. 
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Figure 2.7. The effect of Abcf3 knockdown on SinVand VSV infections. KI shCont-7 and KI 
shAbcf3-8 MEFs were infected with SinV at a MOI of 20. (A) SinV yields from infected KI 
shCont-7 and KI shAbcf3-8 MEFs were measured by plaque assay in BHK cells. (B) SinV 
capsid protein levels from infected KI shCont-7 and KI shAbcf3-8 MEFs were determined by 
Western blotting. (C) KI shCont-7 and KI shAbcf3-8 MEFs were infected with VSV at a MOI of 
5. VSV yields from infected KI shCont-7 and KI shAbcf3-8 MEFs were measured by plaque 
assay in BHK cells. 
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Figure 2.8. The effect of Abcf3 knockdown on WNV infection in B6 MEFs stably 
expressing shRNAs targeting Abcf3. (A) Western blot analysis of Abcf3 protein levels in B6 
shCont-3 and B6 shAbcf3-8 MEFs. B6 shCont-3 and B6 shAbcf3-8 MEFs were infected with 
WNV Eg101 at a MOI of 1. (B) Virus yields from infected B6 shCont-3 and B6 shAbcf3-8 
MEFs were determined by plaque assay in BHK cells. (C) Viral RNA levels were assayed by 
real time qRT-PCR. (D) Viral protein (NS3) levels were measured by Western blotting.  
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DISCUSSION 
The enzymatically inactive Oas1b protein mediates its anti-flaviviral effect by an as yet 
unknown mechanism that is independent of the canonical RNase L pathway (Elbahesh et al., 
2011a; Perelygin et al., 2002; Scherbik et al., 2007a). Twenty-three candidate binding partners of 
Oas1b were identified in a yeast two-hybrid screen of a mouse brain library and 8 of these were 
confirmed by co-transformation of yeast. However, only two of the candidate peptides, ORP1L 
and ABCF3, were identified as interaction partners of Oas1b in vitro. Full length proteins of 
these two partners were also shown to interact with Oas1b in mammalian cells. The lack of an in 
vitro Oas1b interaction for 6 of the 8 putative partners could be due to a false positive interaction 
in yeast or to misfolding or the lack of modification of the in vitro translated peptides. The 
interaction of each of these full length proteins with Oas1b still needs to be tested. The co-
immunoprecipitation results suggest that Oas1b, ORP1L and ABCF3 form a complex in 
mammalian cells. Also, ORP1L and ABCF3 interact with different regions of the Oas1b protein, 
further supporting the idea that these proteins do not compete with each other for Oas1b binding.  
ORP1L belongs to the oxysterol-binding protein (OSBP)-related protein family that is 
involved in processes such as cholesterol maintenance, sterol sensing, lipid transport, and cell 
signaling events (Lehto et al., 2001; Lehto and Olkkonen, 2003; Olkkonen et al., 2006; Xu et al., 
2001; Yan et al., 2007b). ORP1L is one of two variants of ORP1, the other of which is ORP1S 
(Johansson et al., 2003). ORP1L contains an N-terminal extension of ankyrin repeats (a unique 
feature among the OSBP-related proteins) and a pleckstrin homology domain in addition to the 
OSBP domain, whereas ORP1S contains only the OSBP domain common to all OSBP-related 
proteins (Johansson et al., 2003). These two variants differ in their tissue expression, intracellular 
localization and function. ORP1S is predominantly expressed in skeletal muscle and heart, while  
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ORP1L is expressed in macrophages, brain and lungs (Johansson et al., 2003). ORP1S is a 
cytosolic protein while ORP1L localizes to late endosomes (LEs) and colocalizes with LE 
proteins such as Rab7, Rab9, Rab7-interacting lysosomal protein (RILP), and lysosomal 
associated membrane protein 1 (LAMP1) (Johansson et al., 2003; Johansson et al., 2005; 
Johansson et al., 2007).  ORP1L  was  recently  shown  to  be  involved  in  LE  movement  along 
microtubules (Johansson et al., 2005; Johansson et al., 2007; Rocha et al., 2009; Vihervaara et 
al., 2011). Rab7 recruits RILP and ORP1L to form a complex. RILP, present in this complex, 
can interact with the p150
Glued
 subunit of dynactin to recruit the dynein motor complex 
(Johansson et al., 2007). The dynein motor complex then facilitates minus-end-directed 
translocation of LEs towards the microtubule organizing center of the cell (Johansson et al., 
2007; Rocha et al., 2009). The function of ORP1L in this complex is to sense the cholesterol 
content of LEs. In low cholesterol conditions, ORP1L is in an open conformation, exposing a 
motif containing two phenylalanines in an acidic tract (FFAT) that can interact with the vesicle-
associated membrane protein (VAMP)-associated protein A (VAP-A) which removes the 
p150
Glued
 subunit from the motor complex inhibiting the movement of LEs on microtubules. This 
results in a scattered distribution of LEs within the cell (Rocha et al., 2009). In contrast, when 
cholesterol levels are high the ORP1L is in a closed conformation in which the FFAT motif is 
not available for interaction with VAP-A. This facilitates minus-end directed transport of LEs 
(Rocha et al., 2009). A recent study on the effects of ORP1L on LE motility showed that 
knockdown of ORP1L expression results in an increase in LE motility, whereas ORP1L 
overexpression results in the clustering of LEs to the perinuclear region of the cell (Rocha et al., 
2009; Vihervaara et al., 2011). 
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Flaviviruses attach to an unknown cell surface receptor(s) located in a cholesterol raft and then 
enter cells by endocytosis in clatherin-coated pits (Lindenbach, 2007; Medigeshi et al., 2008). 
Acidification of early endosomes leads to a conformational change in the viral envelope (E) 
protein but LE compartment-specific anionic lipids are required to trigger E fusion loop insertion 
into the membrane initiating fusion of the two membranes (Zaitseva et al., 2010). ORP1L 
sensing cholesterol in the lipid rafts of virion-containing LEs would remain in a closed 
conformation facilitating the movement of virion-containing LEs on microtubules (Olkkonen and 
Hynynen, 2009; Xu et al., 2001). For both WNV, SinV and VSV infections, late endosomes are 
the site of virion fusion during entry (Chu and Ng, 2004; Lu et al., 1999; Superti et al., 1987) and 
the negative effect of knocking down Orp1L each of these types of infection could be due to a 
non-specific effect of increased late endosome motility rather than to a specific effect on the 
flavivirus resistance mechanism. Alternative experimental strategies are therefore required to 
study the involvement of ORP1L in the Oas1b-mediated flavivirus resistance mechanism. The 
interaction of Oas1b with ORP1L may stop the movement of virus-containing LEs on 
microtubules and bring them close to the ER.  
The ABC superfamily of ATP-binding proteins is one of the largest protein families 
known with highly conserved ABC proteins found in archaea, prokaryotes, and eukaryotes 
(Hollenstein et al., 2007; Linton and Higgins, 2007; Locher, 2009; Schriml and Dean, 2000; 
Sturm et al., 2009). ABC proteins are canonical transporters of numerous substrates and are 
typically exporters; however, prokaryotic ABC proteins can also function as importers 
(Hollenstein et al., 2007; Locher, 2009). Seven subfamilies of ABC proteins (a-g) have been 
identified in humans. Because the ABCE and ABCF subfamilies are non-canonical ABC 
transporters that lack transmembrane domains (Kerr, 2004; Sturm et al., 2009), it has been 
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suggested that they do not function as typical ABC transporters but instead are involved in other 
processes such as regulating translation initiation and/or elongation, ribosome assembly, and 
RNase L activity (Chen et al., 2006; Kerr, 2004; Martinand et al., 1999; Paytubi et al., 2008; 
Sturm et al., 2009; Tyzack et al., 2000). Although nothing is yet known about ABCF3 protein 
function in mammalian cells, recent reports have suggested that some proteins of both the ABCE 
and ABCF families may share host cell binding partners (Chen et al., 2006; Paytubi et al., 2008; 
Tyzack et al., 2000). Both ABCE and ABCF proteins have been shown to regulate protein 
synthesis by binding translation initiation factors. Data from the present study showed that 
reducing ABCF3 protein levels had the greatest effect on viral protein levels. The 
transmembrane tail of Oas1b specifically localizes it to the ER membrane, the site of flavivirus 
translation and replication and the recruitment of ABCF3 is required for its antiviral affect. The 
mechanism by which ABCF3 specifically decreases flavivirus replication is not yet known, but 
downregulation of WNV protein synthesis would lead to downregulation of viral RNA synthesis 
and progeny virus production. It is possible that the antiviral activity of ABCF3 depends on its 
specific localization to the ER membrane as mediated by binding to Oas1b, which is unique 
among OAS proteins in having a transmembrane domain. 
The ABCE1 protein has also been reported to interact with partners that are not involved 
in translation. ABCE1 was initially reported to be a protein involved in inhibiting RNase L 
activation by binding 2-5As but it was subsequently shown to directly bind to RNase L (Bisbal et 
al., 1995). An equimolar ratio of ABCE1 and RNase L was shown to be required for inhibition 
(Bisbal et al., 1995). However, a previous studies in our lab showed that while RNase L activity 
partially reduces WNV yield, the effect was similar in cells expressing either full length or 
truncated Oas1b and the canonical RNase L pathway was shown not to be involved in the Oas1b-
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mediated resistance to flavivirus-induced disease (Elbahesh et al., 2011a; Scherbik et al., 2006). 
ABCE1 was also reported to bind to TULA, a protein containing both ubiquitin binding domains 
and SH3 domains, leading to the inhibition of the production of HIV-1 viral particles (Agrawal et 
al., 2008; Carpino et al., 2004; Feshchenko et al., 2004; Kowanetz et al., 2004; Smirnova et al., 
2008; Wattenhofer et al., 2001). ABCF3 was also found to interact with Oas1a and Oas1bt 
(Figure 2.2D). What functions it plays when interacting with these proteins are also not currently 
known. ABCF3 may interact with different partners and have different functions depending on 
the complex that it is in.  
 
MATERIALS AND METHODS 
Cell Lines 
C3H/He (He), C3H/RV, C57BL/6 (B6) and C57BL/6-Oas1bKI (KI) SV40-transformed 
mouse embryofibroblast (MEF) lines, as well as BHK-21 W12 cells, were maintained in minimal 
essential medium (MEM) supplemented with 5% heat-inactivated fetal bovine serum (FBS), 
glutamine, and 10 µg/mL gentamicin at 37ºC in 5% CO2. 
He MEFs were transiently transfected with a p3xFLAG-Oas1b plasmid using 
Lipofectamine 2000, according to the manufacturer’s protocol (Invitrogen). Transfected cells 
were selected using 250 µg/mL G418 (Sigma) to create a heterogeneous population of cells 
stably expressing FLAG-Oas1b, referred to here as He-Oas1b cells. Stable integrants from 
individual foci were selected from cloning rings and subsequently expanded. Homogeneous 
clonal cell lines were generated by plating cells at a limiting dilution, harvesting colonies with 
cloning rings and expanding the individual colony cell populations. Multiple clones were 
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selected and analyzed for FLAG-Oas1b protein expression. Clone #12 (He-Oas1b-12) had the 
highest Oas1b expression level and was used for experiments. 
He-Oas1b-12 cells were transfected with pEF6-V5/HIS-TOPO-Orp1L using 
Lipofectamine 2000, according to manufacturer’s protocol (Invitrogen). These cells were then 
selected using 5 µg/mL Blasticidin S hydrochloride (Sigma), as well as G418, to obtain a cell 
population that stably expressed both FLAG-Oas1b and V5-Orp1L, called He-Oas1b/Orp1L. 
The KI (Oas1b-expressing) and B6 (Oas1bt-expressing) MEF lines were previously 
described (Scherbik et al., 2007a) and used for RNAi studies. KI cells were transduced with 
lentiviral-packaged shRNA targeting either mouse Orp1L (sc-62716-V), mouse Abcf3 (sc-
140761-V), or a non-specific shRNA control (sc-108060-V) (Santa Cruz Biotechnology) 
according to the manufacturer’s protocol. Heterogeneous cell populations stably expressing the 
targeted shRNAs were selected using 5 µg/mL puromycin dihydrocholoride (Santa Cruz 
Biotechnology). Clonal lines were selected by plating cells at a limiting dilution, harvesting 
colonies with cloning rings and expanding the individual colony cell populations. The 
knockdown efficiency of each clone was determined using Western blotting to detect protein and 
real time qRT-PCR to detect mRNA. The KI shControl clone #7 (KI shCont-7) cells had 
comparable levels of Orp1L and Abcf3 to the wildtype KI cells and were used in the 
experiments. The same protocol was used to generate B6 shControl clone #3 (B6 shCont-3) cells.  
 
cDNA Constructs 
The full length Oas1b cDNA was amplified from C3H/RV RNA by RT-PCR, cloned into 
a pScreen vector (Invitrogen) and then subcloned into the pGBKT7 vector (Clontech) using 
Nco1 and BamH1 restriction enzyme sites. Similarly, full length Oas1b was amplified from 
49 
 
 
C3H/RV RNA, cloned into a TOPO vector (Invitrogen) and then subcloned into the pEBG 
vector (a gift from Dr. Hobman, University of Alberta) that fuses an N-terminal GST tag onto the 
expressed protein (GST-Oas1b). Also, truncated Oas1b (Oas1bt) was amplified from C3H/He 
RNA, cloned into a TOPO vector and then subcloned into the pEBG vector (GST-Oas1bt). A 
construct expressing an Oas1b protein without the predicted C-terminal transmembrane domain 
(Oas1bΔTM) was generated by PCR amplification of the cDNA sequence corresponding to 
amino acids 1-353 of the Oas1b protein using the forward primer 5′-
CATATGATGGAGCAGGATCTG-3′ and the reverse primer 5′-
GAATTCCTAATACTTCATTGG-3′ followed by cloning into a TOPO vector and then 
subcloning into pGBKT7 (Clontech) using Nde1 and EcoR1 restriction enzyme sites. For 
mammalian cell expression, Oas1b cDNA was subcloned from a pNTAP-Oas1b plasmid into the 
p3xFLAG-CMV-10 vector (Sigma) using EcoR1 and Xba1 restriction sites (p3xFLAG-Oas1b). 
Full length Orp1L cDNA was reverse transcribed from He cell RNA using a Thermoscript RT-
PCR kit (Invitrogen) with the Orp1LF forward primer 5′-
GCCATGAACACAGAAGCAGAACAGCAGCTTCTC-3′ and the Orp1LR reverse primer 5′-
ATAAATATCAGGCAAATTGAAGTAGTTTCTGTC-3′ then PCR amplified using the 
Platinum Taq DNA Polymerase High Fidelity kit (Invitrogen) using the Orp1LF and Orp1LR 
primers and subsequently cloned into the pEF6-V5/HIS-TOPO vector (Invitrogen), creating the 
pEF6-V5/HIS-TOPO-Orp1L (pEF6-Orp1L) construct for mammalian cell expression. All 
constructs were sequenced to verify that they contained the correct sequence. 
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Transient Transfection 
BHK cells were seeded to approximately 80% confluency and transiently transfected 
with cDNA expressing GST-Oas1b, GST-Oas1bt, or GST tag alone using Lipofectamine 2000 
(Invitrogen) according to manufacturer’s protocol.  
 
Viruses 
A stock of lineage 1 WNV strain Eg101 was prepared by infecting a monolayer of BHK 
cells at a multiplicity of infection (MOI) of 0.1 and harvesting culture fluid at 32 hr after 
infection. Clarified culture fluid (5x10
7
 PFU/ml) was aliquoted and stored at -80ºC. A stock of 
Sindbis virus strain SAAR339 (7x10
9
 PFU/ml) was prepared as a 10% (wt/vol) newborn mouse 
brain homogenate.  
 
Plaque Assay 
Infectivity titers were determined by infecting monolayers of BHK cells in duplicate well 
of a six-well plate with serial 10-fold dilutions of clarified culture fluid. After adsorption for 1 hr 
at RT, the virus inoculum was removed and the wells were overlaid with 1% SeaKem ME 
agarose (Bio-Whittaker Molecular Applications, Rockland, Maine), mixed 1:1 with 2x MEM 
containing 5% FBS, and incubated for 72 hr at 37ºC in 5% CO2. Plaque assays were performed 
in BHK cells with the same protocol for SinV but the plates were incubated for 48 hr. After 
removal of the agarose plugs, cells were stained with 0.05% crystal violet in 10% ethanol. 
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Yeast Two-Hybrid Analysis 
Yeast two-hybrid analyses were performed according to manufacturer’s protocol 
(Clontech). Oas1bΔTM was cloned into the pGBKT7 vector (Clontech) which was transformed 
into AH109 yeast cells (bait). The Oas1bΔTM-transformed AH109 cells were mated with pre-
transformed Y187 yeast cells (Mouse Brain cDNA library (prey)) (Clontech). Yeast two-hybrid 
analysis yielded a mating efficiency of ~1.58% and approximately 2.1x10
6
 clones were screened. 
Diploid yeast cells were plated onto triple drop-out (TDO; SD/-His/-Leu/-Trp) agarose selection 
plates and incubated at 30ºC. Colonies were selected from TDO plates and re-streaked onto 
quadruple drop-out (QDO; SD/-Ade/-His/-Leu/-Trp) agarose plates for a more stringent 
secondary selection. Colonies growing on QDO selection plates were then further tested for 
Gal4-mediated MEL1 activation, one of the Gal4-responsive reporter genes of the yeast two-
hybrid system. Alpha-glactosidase production from MEL1 turns X-α-Gal into a blue product and 
therefore suggests a positive interaction. 
 
Yeast Co-transformation 
A yeast co-transformation analysis was performed according to the manufacturer’s 
protocol (Clontech). Oas1bΔTM-transformed AH109 yeast cells were mated with individual 
putative partner positive clones transformed into Y187 yeast cells and diploid cells were plated 
onto double drop-out (DDO; SD/-Leu/-Trp) selection plates to confirm co-transformation, as 
well as onto QDO plates to confirm a positive interaction identified in the yeast two-hybrid 
screen. 
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In Vitro Transcription and Translation 
Putative positive clones and bait constructs were in vitro transcribed and translated in the 
presence of 20 µCi 
35
S-labeled methionine (EasyTag
TM
 Met L-[
35
S] Perkin Elmer), according to 
manufacturer’s protocol (Promega).   
 
In Vitro Co-immunoprecipitation 
Two 
35
S-methionine-labeled, in vitro translated peptides were incubated together for 1 hr 
at RT. The reaction was then divided into two and incubated with either a control (agarose alone 
or anti-IgG antibody) or with anti-HA antibody (Roche) for 1 hr with rotation at 4ºC, after which 
Protein G agarose (Roche) was added and rotation was continued at 4ºC overnight. The beads 
were then washed 3 times in lysis buffer (1% Triton X-100, 0.1% SDS, 150 mM NaCl, 50 mM 
Tris HCl pH 7.4, and fresh protease inhibitor). The beads were centrifuged and 30 µl of 2x 
sample buffer (20% SDS, 25% glycerol, 0.5 M Tris HCl pH 6.8, and 0.5% bromophenol blue) 
was added and the samples were boiled at 95ºC to denature the protein complexes. 
Immunoprecipated proteins were separated by SDS-PAGE in 10% polyacrylamide gels. Gels 
were washed 3 times in fixing solution (10% acetic acid and 30% methanol) to remove free 
radiolabeled methionine and then incubated for 30 min at RT in Autofluor (National 
Diagnostics), incubated for 5 min at RT in an anti-cracking buffer (7% acetic acid, 7% methanol, 
and 1% glycerol), and then dried onto 3 mm chromatography paper (Whatman) using a Model 
543 Gel Dryer (BIO-RAD). Dried gels were exposed to HyBlot CL® autoradiography film 
(Denville) at -80ºC and bands were detected by autoradiography. 
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Mammalian Cell Co-immunoprecipitation 
Approximately 2x10
7
 cells were washed twice with 1xPBS and then treated with 0.5 mM 
dithiobis[succinimidyl propionate] (DSP) for 30 min at RT to crosslink cellular proteins. The 
reaction was quenched with 50 mM Tris pH 7.5 for 15 min on ice. The cells were rinsed in 
1xPBS, incubated on ice for 30 min after the addition of 1.5 ml lysis buffer and then passed 
through a 21 gauge syringe. Cell lysates were clarified by centrifugation at 2,000 x g at 4ºC for 5 
min. The supernatant was divided in two and incubated with either anti-IgG antibody-conjugated 
Protein G agarose beads (Sigma) or with anti-FLAG antibody-conjugated Protein G agarose 
beads (Sigma) at 4ºC overnight. The beads were washed 3 times in lysis buffer to remove 
unbound proteins, centrifuged and 30 µl of 2x sample buffer was added. Sample buffer contains 
β-mercaptoethanol which reverses the chemically crosslinked proteins from the DSP treatment. 
The beads were boiled at 95ºC for 5 min to denature the protein complexes and the samples were 
sonicated. Immunoprecipitated proteins were separated by SDS-PAGE and transferred to a 
nitrocellulose membrane for 1 hr at 100V. After transfer, membranes were blocked for 1 hr at RT 
in 5% non-fat dry milk (NFDM), incubated with a primary antibody diluted in 5% NFDM 
overnight at 4ºC, washed 3 times for 10 min in 1xTBS+Tween 20 and then incubated with a 
secondary antibody diluted in 5% NFDM for 1 hr at RT. Membranes were washed twice in 
1xTBS+Tween 20, once in 1xTBS for 10 min at RT and then incubated in SuperSignal West 
Pico Chemiluminescent Substrate (Thermo Scientific) for 5 min at RT and bands were detected 
by autoradiography. 
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Antibodies 
The primary antibodies used in immunoblotting experiments were: mouse anti-c-Myc and 
mouse anti-HA (Roche), mouse anti-FLAG, rabbit anti-FLAG, and rabbit Abcf3 (Sigma), goat 
anti-V5 (Bethyl Laboratories), goat anti-NS3 (R&D Systems), and rabbit anti-Orp1L R247 (a 
kind gift from Dr. Olkkonen, Helsinki, Finland). The primary antibodies used in confocal 
microscopy studies were: mouse anti-GST, rabbit anti-GST (Cell Signaling), rabbit anti-Calnexin 
(Sigma), mouse anti-CoxIV (Invitrogen), and mouse anti-dsRNA (Hungary). Secondary 
antibodies used for immunoblotting experiments included anti-Rabbit-HRP, anti-Mouse-HRP 
(Cell Signaling), and anti-Goat-HRP (SCBT). Secondary antibodies used for confocal 
microscopy studies included donkey anti-Mouse Alexa Fluor 594, donkey anti-Mouse Alexa 
Fluor 488, donkey anti-Rabbit Alexa Fluor 488, and donkey anti-Rabbit Alexa Fluor 594 
(Invitrogen).   
 
Confocal Microscopy 
BHK cells were seeded onto 3 mm coverslips (Fisher Scientific) in 24-well plates and 20 
hr later infected with WNV Eg101 at an MOI of 1, fixed with 4% paraformaldehyde in 
phosphate buffered saline (PBS) for 10 min at RT, permeablized with 0.1% Triton X-100 in PBS 
for 10 min, and rinsed three times with PBS, and incubated overnight at 4ºC in blocking buffer 
(5% horse serum in PBS). Primary antibodies were diluted in blocking buffer and incubated with 
cells for 1 hr at RT. The cells were washed three times for 10 min in PBS and then incubated 
with the secondary antibodies and 0.5 µg/ml Hoechst 33258 dye (Invitrogen) for 1 hr at RT. 
Coverslips were mounted using ProLong Gold Antifade reagent (Invitrogen) and images were 
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taken with a LSM 510 confocal microscope (Zeiss, Oberkochen, Germany) using a 63x water-
immersion objective. Images were analyzed using Zeiss LSM Image Browser software. 
 
Real time qRT-PCR 
Total cellular RNA was isolated from B6 and KI cells with TriReagent (Molecular 
Research Center). Cellular and viral RNA were quantified using a TaqMan One-Step RT-PCR 
Master Mix Reagents Kit (Applied Biosystems) according to manufacturer’s protocol. Mouse 
Orp1L (Mm_00498552_m1) and mouse Abcf3 (Mm_00658695_m1) cellular RNA levels were 
measured using predesigned primer and probe sets (Applied Biosystems). WNV Eg101 NS1 
RNA was measured using a previously described primer and probe set (Scherbik et al., 2006). 
Mouse GAPDH was used as an internal loading control.   
 
MTT Assay 
Cells were plated to ~100% confluency in 96-well plates and infected with WNV Eg101 
at a MOI of 1. Cell viability was determined at 24 hr and 48 hr after infection using a CellTiter 
96® non-radioactive cell proliferation assay done according to manufacturer’s protocol 
(Promega). 
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CHAPTER 3 
 
Specific Aim 2: To analyze the formation of virus-induced stress granules during infection 
of BHK cells with a WNV lineage 1/2-based infectious clone. 
 
INTRODUCTION 
West Nile virus is maintained in nature in a mosquito-bird transmission cycle and has 
recently become endemic in the United States. Humans and horses are occasionally infected but 
are dead end hosts (Brinton, 2002; Lindenbach, 2007). Infections in humans are usually 
asymptomatic but some individuals develop fever and/or flu-like symptoms and a few of these 
progress to central nervous system disease (Brinton, 2002; Lindenbach, 2007). WNV belongs to 
the family Flaviviridae, genus Flavivirus, which includes other mosquito-borne human 
pathogens such as dengue virus, yellow fever virus (YFV) and Japanese encephalitis virus. The 
WNV genome is a positive-sense, single-stranded RNA that contains a 5′ cap but no 3′ poly(A) 
tail (Lindenbach, 2007). It is approximately 11,000 nts in length and encodes a single 
polyprotein that is co- and post-translationally processed by both host and viral proteases into 
three structural [capsid (C), membrane (M) and envelope (E)] and seven non-structural (NS1, 
NS2a, NS2b, NS3, NS4a, NS4b and NS5) proteins (Lindenbach, 2007). Most of the more than 
70 strains of WNV are classified in either lineage 1 or 2 (Bakonyi et al., 2006; Lanciotti et al., 
2002; Prilipov et al., 2002). Lineage 1 WNV strains are endemic in northern Africa, Europe, the 
Middle East, parts of Asia and the Americas, while lineage 2 WNV strains are typically found in 
sub-Saharan Africa (Bakonyi et al., 2006; Lanciotti et al., 2002; Prilipov et al., 2002).   
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In response to several types of cellular stress, eukaryotic translation initiation factor 2 
alpha (eIF2α) Ser51 is phosphorylated by one of four kinases: protein kinase R (PKR), activated 
by dsRNA (viral infection); heme-regulated initiation factor 2α (HRI), activated by oxidative 
stress; PKR-like endoplasmic reticulum kinase (PERK), activated by unfolded proteins in the 
endoplasmic reticulum (ER); and general control nondepressible 2 (GCN2), activated by amino 
acid starvation (Anderson and Kedersha, 2008). Phosphorylation of eIF2α reduces the amount of 
available eIF2-GTP-tRNA complexes and thus inhibits translation initiation resulting in 
polysome disassembly through ribosome runoff. RNA-binding proteins such as TIA-1, TIAR, 
and G3BP can then bind to the 5′ end of the mRNA with a stalled initiation complex and 
aggregate with other mRNA-bound proteins forming microscopically visible stress granules 
(SGs) (Anderson and Kedersha, 2002a, 2008). SGs recruit many additional proteins including 
RNA-stabilizing proteins (Anderson and Kedersha, 2008; Brennan and Steitz, 2001). Although 
cap-dependent translation is suppressed in stressed cells, translation from internal ribosome entry 
site (IRES) elements and alternative ORFs, such as those in the mRNAs of heat shock proteins, 
chaperones, and some transcription factors (i.e. ATF4), still occurs (Vattem and Wek, 2004). If a 
cell survives the stress, SGs dissociate and the mRNAs resume translation (Brennan and Steitz, 
2001). However, if a cell is unable to recover and enters apoptosis, stalled mRNAs in SGs are 
transported to and degraded by processing bodies (PBs) (Sheth and Parker, 2003; Teixeira et al., 
2005). Some virus infections have been shown to suppress SG formation (Dougherty et al., 2011; 
McInerney et al., 2005; White et al., 2007). Lineage 1 WNV Eg101 infections in BHK cells were 
previously reported not to induce SGs but to inhibit SG induction by arsenite treatment (Emara 
and Brinton, 2007). A subsequent study showed that infections with the lineage 2/1 infectious 
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chimeric W956IC virus activated PKR while WNV Eg101 infections did not (Elbahesh et al., 
2011b). 
In the present study, SG induction in BHK cells by infections with additional natural 
lineage 1 or lineage 2 WNV strains and W956IC was compared. None of the natural lineage 1 or 
lineage 2 WNV strains tested induced SGs by 24 hr after infection while W956IC virus 
infections efficiently induced SGs starting at 12 hr after infection. All SG-positive, WNV-
infected cells had elevated levels of phosphorylated eIF2α. PKR was identified as the kinase 
phosphorylating eIF2α in WNV-infected cells. Mapping experiments done with a set of WNV 
chimeric viruses suggested that interactions between viral nonstructural proteins and/or between 
viral nonstructural proteins and cell proteins are altered in W956IC-infected cells. Increased 
levels of SG-positive, chimeric virus-infected cells correlated with higher levels of early viral 
RNA synthesis and the presence of viral dsRNA that was not protected by intracellular 
membranes. 
 
RESULTS 
Efficiency of SG formation induced by different strains of WNV 
It was previously reported that lineage 2-based W956IC virus infections induced PKR 
phosphorylation while lineage 1 WNV Eg101 infections did not (Elbahesh et al., 2011b). WNV 
Eg101 infections were previously reported not to induce SGs (Emara and Brinton, 2007). To 
determine whether different strains of WNV varied in the efficiency with which they induced 
SGs, BHK cells were infected with WNV lineage 1 strains, Eg101, NY99 or Tx113; with WNV 
lineage 2 strains, B956, Mg78, or SPU; or with a lineage 1/2-based chimeric WNV infectious 
clone, W956IC virus. Cells were fixed at 36 hr after infection and analyzed by confocal 
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microscopy. Less than 3% of the infected cells were SG-positive by 36 hr after infection with 
each of the lineage 1 and 2 WNV strains tested (Figure 3.1A), confirming our previous results 
(Emara and Brinton, 2007). In contrast, W956IC infections induced SGs in ~30% of the infected 
BHK cells by 36 hr after infection (Figure 3.1A and C). 
The time course of SG formation in Eg101- and W956IC-infected cells was next 
analyzed. BHK cells were infected with either WNV Eg101 or W956IC (MOI of 1) and then 
fixed and analyzed for SGs at various times after infection. Less than 0.5% of the mock-infected 
cells contained SGs at either 24 hr or 36 hr after infection (Figure 3.1B and C). No SG-positive 
WNV Eg101-infected cells were detected at either 6 hr or 12 hr after infection, whereas SG-
positive W956IC-infected cells were observed by 12 hr. By 24 hr (less than 1%) and by 36 hr 
(less than 3%) of Eg101-infected cells contained SGs (Figure 3.1B and C). In contrast, ~20% of 
the W956IC-infected cells were SG-positive at 24 hr after infection and ~30% were SG-positive 
by 36 hr (Figure 3.1B and C). Differential efficiency of SG induction by Eg101 and W956IC 
virus infections was also observed in C3H/He MEFs, C57BL/6 MEFs, and HEK 293T cells (data 
not shown). Although the number of SG-positive infected cells and the time at which they 
initially appeared differed among the cell lines tested, W956IC infections consistently induced 
SGs at earlier times after infection as well as higher levels of SG-positive, infected cells 
compared to Eg101 infections. 
During stress, stalled pre-mRNA complexes are held in SGs and when the fate of the cell 
is decided, either mRNA translation is reinitiated or the mRNAs are transferred to PBs for 
degradation (Anderson and Kedersha, 2008; Beckham and Parker, 2008; Sheth and Parker, 
2003). Alterations of PB number occurs in response to various stress stimuli and our lab 
previously reported that the number of PBs in WNV Eg101 and dengue 2 virus infected BHK 
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Figure 3.1. Stress granule formation induced by different strains of WNV. (A) BHK cells 
were infected with the indicated lineage 1 or lineage 2 WNV strain at a MOI of 1, fixed at 36 hr 
after infection and analyzed by confocal microscopy. Anti-G3BP antibody (green) was used to 
detect SGs, anti-dsRNA antibody (red) to detect WNV-infected cells and Hoechst dye (blue) to 
detect nuclei. Merged images are shown. (B) BHK cells were infected with either Eg101 (lineage 
1) or W956IC (lineage 2-based infectious clone) at a MOI of 1 and analyzed for SG formation at 
the indicated times after infection. Antibody staining was the same as in panel A. Cells were 
collected at the indicated times after infection. Merged images are shown. (C) SG-positive 
infected cells were counted to determine the percentage of Eg101- and W956IC-infected cells 
containing SGs. * - represents significance compared to mock-infected cells at a 95% confidence 
interval (p < 0.05). ** - represents significance compared to Eg101-infected cells at a 95% 
confidence interval (p < 0.05). (D) BHK cells were infected with either Eg101 or W956IC at a 
MOI of 1 and analyzed for PB formation in infected cells. Anti-Dcp1a antibody (green) was used 
as a marker for PBs, anti-dsRNA antibody (red) was used to detect virus-infected cells, and 
Hoechst dye (blue) was used to detect nuclei. Merged images are shown. (E) PBs were counted 
to determine the average number per infected cell. * - represents significance compared to mock-
infected cells at a 95% confidence interval (p < 0.05). Error bars indicate standard deviation of 
the mean. 
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cells was reduced by 24 hr after infection (Emara and Brinton, 2007; Teixeira et al., 2005). To 
determine the effect of a W956IC virus infection on PBs, W956IC-infected BHK cells were 
fixed at 36 hr after infection and analyzed by confocal microscopy. Mock-infected cells 
contained an average of ~70.93 PBs/cell, whereas Eg101-infected cells had ~47.5 PBs/cell and 
W956IC-infected cells had ~39.03 PBs/cell (Figure 3.1E). Both Eg101 and W956IC infections 
reduced PB numbers in infected cells with a slightly greater reduction seen in the W956IC-
infected cells. PB numbers were also reduced in BHK cells infected with the NY99, Tx113, 
B956, Mg78, and SPU strains of WNV compared to mock infected cells (data not shown).  
 
SG formation in WNV-infected cells is PKR-dependent 
The phosphorylation of eIF2α which leads to SG formation in mammals is mediated by 
four kinases, PKR, PERK, GCN2 and HRI (Anderson and Kedersha, 2008). To determine which 
of these four eIF2α kinases mediates SG induction in WNV-infected cells, the eIF2α kinase 
knockout MEF cell lines PKR
-/-
, PERK
-/-
, GCN2
-/-
, and HRI
-/-
 (Han et al., 2001; Harding et al., 
2000; Yang et al., 1995) were mock-infected or infected with WNV Eg101 or W956IC at a MOI 
of 1 and then fixed at 24 hr after infection and analyzed by confocal microscopy. C57BL/6 (B6) 
and PERK
+/+
 (a second C57BL/6 cell line) MEFs that express all four of the eIF2α kinases were 
used as controls (Harding et al., 2001). SGs were detected in both Eg101- and W956IC-infected 
control, PERK
-/-
, GCN2
-/-
 and HRI
-/-
 MEFs (Figure 3.2A). Quantification of the number of SG-
positive, infected cells indicated that the control, PERK
-/-
, GCN2
-/-
, and HRI
-/-
 MEF cultures each 
contained 8-12% SG-positive Eg101-infected cells or 15-20% SG-positive W956IC-infected 
cells at 24 hr (Figure 3.2B). However, no SGs were observed in PKR
-/-
 cells infected with either 
virus (Figure 3.2A and B), indicating that SG induction in WNV-infected cells is PKR-  
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Figure 3.2. Stress granule formation induced by WNV infection is PKR-dependent. (A) 
Control MEFs (C57Bl/6 and PERK
+/+
) and eIF2α kinase knockout MEFs (PKR-/-, PERK-/-, 
GCN2
-/-
, and HRI
-/-
) were infected with WNV Eg101 or W956IC at a MOI of 1, fixed at 24 hr 
after infection and analyzed by confocal microscopy. SGs were detected with anti-G3BP 
antibody (green), WNV-infected cells with anti-dsRNA antibody (red), and nuclei with Hoechst 
dye (blue). Arrows denote SG-positive cells. Merged images are shown. (B) The total number of 
cells and the number of SG-positive, infected cells were counted and the percentage of infected 
cells containing SGs was determined as described in the Materials and Methods. * - represents 
significance compared to PERK
+/+
 control cells for the indicated infection at a 95% confidence 
interval (p < 0.05). (C) During the course of infection, BHK cells were treated with different 
concentrations of 2-AP or DMSO (vehicle control), infected with W956IC at a MOI of 1, fixed 
at 24 hr after infection and analyzed by confocal microscopy to observe SG formation in infected 
cells. The percent of SG-positive, infected cells was calculated. (D) An MTT assay measuring 
cell viability during treatment of BHK cells infected with W956IC and treated with different 
concentrations of 2-AP or DMSO was performed as described in the Materials and Methods. 
Error bars indicate standard deviation of the mean. 
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dependent. Unlike BHK cells, these MEF cell lines are interferon (IFN)-competent and it was 
previously reported that IFN production during WNV Eg101 infections leads to elevated levels 
of PKR and phosphorylated PKR in IFN-competent cells as compared to IFN
-/-
 cells (Elbahesh et 
al., 2011b), possibly leading to the slight induction of SGs in Eg101-infected MEF cell cultures; 
however, W956IC-infected MEFs still induced higher levels of SG-positive, infected cells 
compared to Eg101-infected cells. 
As an alternative means of showing that PKR is the kinase responsible for the formation 
of SGs in WNV-infected cells, BHK cells were incubated with 2-aminopurine (2-AP), a purine 
analog that is a potent PKR inhibitor (Hu and Conway, 1993; Lindquist et al., 2011b). BHK cells 
were infected with W956IC virus (MOI of 1) for an hr and then incubated in media containing 2-
AP or DMSO (solvent control) for 24 hr. Approximately 20% of the W956IC-infected cells were 
SG-positive in untreated, DMSO-treated and 0.2 mM 2-AP-treated cultures (Figure 3.2C). Only 
10% of W956IC-infected cells were SG-positive in the 1 mM 2-AP-treated cultures and 3% were 
SG-positive in 5 mM 2-AP-treated cultures (Figure 3.2C). An MTT assay showed a <4% 
decrease in cell viability after of 0.2 mM 2-AP treatment, <6% decrease after 1 mM 2-AP 
treatment, and ~25% decrease after 5 mM 2-AP treatment of W956IC-infected cells (Figure 
3.2D). The results suggest that the dose-dependent decrease in SG formation observed with 2-AP 
treatment was not due to a decrease in cell viability and further confirm that PKR is the kinase 
responsible for SG formation during infection. 
To determine whether PKR plays an antiviral role during WNV infections, wildtype 
C57BL/6 and PKR
-/-
 MEFs were infected with Eg101 or W956IC at a MOI of 1. Clarified 
culture fluids and cell lysates were collected for growth curve and Western blot analyses. These 
results showed that Eg101 infections, which slightly induce SGs in MEFs, were only slightly  
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Figure 3.3. WNV Eg101 and W956IC infections replicate to higher levels in PKR
-/-
 MEFs. 
(A) Wildtype C57BL/6 and PKR
-/-
 MEFs were infected with WNV Eg101 and W956IC at a MOI 
of 1. Virus yields were measured by plaque assay at the indicated times after infection. (B) 
Western blot analysis of C57BL/6 and PKR
-/-
 MEFs infected with WNV Eg101 or W956IC at a 
MOI of 1. Lysates were collected in RIPA buffer at the indicated times after infection and 
analyzed using antibodies to viral NS3, PKR, and actin. 
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increased in both the viral titers and viral NS3 protein in PKR
-/-
 MEFs as compared to control 
cells, whereas W956IC infections that significantly induce SGs in MEFs showed dramatic 
increases in both viral titers and viral NS3 protein in PKR
-/-
 MEFs (Figure 3.3A and B). These 
results suggest that PKR activation leading to SG formation during WNV infections is antiviral 
and suggests that avoiding PKR activation during WNV infection is advantageous to viral 
synthesis. 
 
W956IC infections induce higher levels of phosphorylated PKR and phosphorylated eIF2α 
in BHK cells at early times after infection 
Since activation of the Type I interferon signaling pathway has been reported to result in 
PKR activation (Su et al., 2006), BHK cells that are not responsive to Type I interferon were 
used for all subsequent experiments to insure that the PKR activation observed was due to the 
infection. Consistent with the higher number of SG-positive cells in W956IC-infected BHK 
cultures, higher levels of activated PKR (phosphorylated at Thr451) and phosphorylated eIF2α 
would also be expected in these cultures compared to WNV Eg101-infected cultures. Cell lysates 
collected at various times after infection with WNV Eg101 or W956IC were analyzed by 
Western blotting for total and phosphorylated PKR and eIF2α. PKR phosphorylation was not 
detected in any of the WNV Eg101-infected lysates; however, phosphorylated PKR was detected 
in the W956IC samples from 16 through 28 hr after infection (Figure 3.4A). eIF2α 
phosphorylation in W956IC-infected cells was detected starting at 16 hr after infection (Figure 
3.4A). Because a more sensitive Western blot detection system was used in this study than in our 
previous study (Emara and Brinton, 2007), some phosphorylated eIF2α was detected at 24 and 
28 hr after infection with WNV Eg101. In contrast, similar levels of total eIF2α were detected by  
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Figure 3.4. W956IC-infected cells have elevated levels of phosphorylated PKR and eIF2α. 
(A) Western blot analysis of BHK cells infected with WNV Eg101 or W956IC at a MOI of 1. 
Lysates were collected in RIPA buffer at the indicated times after infection and analyzed using 
antibodies specific for the detection of phosphorylated PKR (Thr541), PKR, phosphorylated 
eIF2α (Ser51), eIF2α, and actin. (B) BHK cells were infected with WNV Eg101 or W956IC at a 
MOI of 1, fixed at 24 hr after infection and analyzed by confocal microscopy. Anti-G3BP 
antibody (green) was used to detect SGs and anti-p-eIF2α antibody (white) to detect p-eIF2α. 
More than 95% of the cells were infected. 
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16 hr after infection with either virus. The increase in eIF2α phosphorylation in the Eg101-
infected cells in the absence of PKR phosphorylation suggested that it was due to the activation 
of another eIF2α kinase. The increase in phosphorylated eIF2α at later times of infection 
correlated with the increase in SG-positive, WNV Eg101-infected BHK cells from <1% at 24 hr 
to <3% at 36 hr after infection.  
To determine whether SG-positive, infected cells contained elevated levels of 
phosphorylated eIF2α, BHK cells were infected with WNV Eg101 or W956IC, fixed at 24 hr 
after infection and analyzed by confocal microscopy. The level of p-eIF2α was high in all cells 
that were SG-positive (Figure 3.4B). However, not all p-eIF2α-positive cells contained SGs (data 
not shown) suggesting that there may be a threshold level of p-eIF2α needed for SG induction or 
that additional cell factors/conditions may also be involved in SG formation.  
 
Mapping the viral determinants involved in enhanced SG induction by W956IC virus 
infection 
The W956IC cDNA plasmid is very stable in bacteria and has been a useful tool for 
recovering WNV genomes with engineered mutations (Basu and Brinton, 2011). The W956IC 
cDNA was constructed from a highly passaged WNV B956 virus stock designated 956D117B3 
(Yamshchikov et al., 2001). The 956D117B3 sequence differs from that of B956 by 32 single nt 
substitutions within the coding region (Yamshchikov et al., 2004; Yamshchikov et al., 2001). 
Although 956D117B3 cDNA was used to construct the majority of the W956IC infectious clone, 
the C-terminus of the NS5 gene through the 3′ UTR region was amplified from WNV Eg101 
genomic RNA (Yamshchikov et al., 2001). To identify viral components associated with less 
efficient SG induction, additional chimeric W956IC genomes were made by replacing one or  
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Figure 3.5. Schematic representation of the WNV W956IC-Eg101 chimera genomes. Eg101 
sequences are shown in grey and W956IC sequences are shown in blue. The majority of the 
W956IC genome sequence is from D117B956 but the C-terminus of NS5 and the 3′ UTR are 
from Eg101. Additional chimeric viruses were created by replacing one or more W956IC genes 
with the Eg101 equivalent on the W956IC backbone.  
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more W956IC genes with the Eg101 equivalent as described in the Materials and Methods. Eg-C 
(capsid), Eg-NS1, Eg-NS2a, Eg-NS3+4a, Eg-NS4b, Eg-NS5, Eg-NS1+3+4a, and Eg-NS1+5 
chimeric viruses were constructed (Figure 3.5). All of the chimeric WNV infectious clones 
constructed contained the 3′ UTR from Eg101 and all but the Eg-NS5 and Eg-NS1+5 clones 
contained the 956D117B3/Eg101 hybrid NS5 gene. 
BHK cells were infected with one of the chimeric viruses, fixed at 36 hr after infection 
and analyzed for SGs by confocal microscopy. Consistent with the data shown in Figure 3.1, 
WNV Eg101 infections induced SGs in <3% of infected cells while W956IC infections induced 
SGs in ~30% of the infected cells at 36 hr after infection (Figure 3.6A and B). The Eg-NS1 
(~7%), Eg-NS2a (~15%), Eg-NS3+4a (~8%), Eg-NS4b (~10%), and Eg-C (~20%) chimeric 
virus infections induced intermediate numbers of SG-positive, infected cells by 36 hr after 
infection, while the Eg-NS5 (<3%), Eg-NS1+3+4a (<3%), and Eg-NS1+5 (<3%) chimeric virus 
infections induced few SG-positive, infected cells similar to Eg101 infections (Figure 3.6A and 
B). The data indicate that either the replacement of the N-terminal region of NS5 or of the NS1, 
NS3 and NS4a genes with Eg101 sequence recreated the WNV Eg101 SG phenotype. 
The growth kinetics of the various chimeric viruses was analyzed to determine whether 
the differential SG phenotypes were due to differences in the growth efficiencies of these 
viruses. BHK cells were infected with WNV Eg101, W956IC or one of the chimeric viruses at a 
MOI of 1 and culture fluid was collected at various times after infection. Eg101 and W956IC 
infections produced similar virus yields at 24 and 36 hr after infection (Figure 3.6C). However, 
W956IC infections produced significantly more progeny virus than Eg101 infections at 12 hr 
after infection (Figure 3.6C). The yields produced by Eg-C, Eg-NS1, Eg-NS2a, Eg-NS3+4a, and 
Eg-NS4b chimeric virus infections at 12 hr were similar to that produced by a W956IC infection, 
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while the 12 hr yields from Eg-NS5, Eg-NS1+3+4a, and Eg-NS1+5 infections were comparable 
to that from an Eg101 infection (Figure 3.6C). Virus yields from the Eg-C, Eg-NS1, Eg-NS2a, 
Eg-NS3+4a, and Eg-NS4b chimeric virus infections at 24 and 36 hr were similar to those of both 
the Eg101 and W956IC infections (Figure 3.6C). However, the Eg-NS5 and Eg-NS1+3+4a 
chimeric virus infections produced slightly reduced virus yields at 24 and 36 hr after infection. 
Although the yield of Eg-NS1+5 virus was slightly decreased at 24 hr, levels comparable to 
Eg101 and W956IC virus infections were observed by 36 hr (Figure 3.6C). These data indicate 
that the replication efficiencies of none of the chimeric viruses were significantly compromised. 
Since PKR is activated by double stranded regions of viral RNA (Garcia et al., 2007), the 
levels of intracellular viral plus strand RNA produced by Eg101, W956IC and the chimeric 
viruses early after infection was next assessed. BHK cells were infected with WNV Eg101, 
W956IC or a chimeric virus at a MOI of 1 and total cellular RNA was collected at 12 hr after 
infection. The number of viral genome copies per 1 µg of total RNA was quantified as described 
in the Materials and Methods. Consistent with the 12 hr viral yields, W956IC infections 
synthesized the highest levels of viral RNA by 12 hr after infection while Eg101 infections 
synthesized the least (Figure 3.6D). The Eg-C, Eg-NS1, Eg-NS2a, Eg-NS3+4a and Eg-NS4b 
chimeric virus infections produced higher levels of early intracellular viral RNA like a W956IC 
infection, while the Eg-NS5, Eg-NS1+3+4a, and Eg-NS1+5 infections produced lower levels of 
early viral RNA similar to an Eg101 infection (Figure 3.6D). The results indicate that more 
efficient SG induction in infected cells correlates with increased levels of viral RNA synthesis at 
early times after infection. The data further suggest that interaction between viral nonstructural 
proteins and possibly also between nonstructural proteins and viral RNA and/or cell proteins are  
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Figure 3.6. The levels of early viral RNA synthesis correlate with the level of SG-positive, 
infected cells and virus yield. (A) BHK cells were infected with the indicated WNV chimeric 
virus at a MOI of 1, fixed at 36 hr after infection and analyzed by confocal microscopy. SGs 
were detected with anti-G3BP antibody (green), WNV-infected cells with anti-dsRNA antibody 
(red), and nuclei with Hoechst dye (blue). Merged images are shown. (B) Total and SG-positive, 
infected cells were counted and the percentage of infected cells containing SGs was determined. 
* - Significance compared to W956IC was determined at a 95% confidence interval (p < 0.05). 
(C) BHK cells were infected with the indicated chimeric virus at a MOI of 1 and the virus yield 
was determined by plaque assay. (D) BHK cells were infected with the indicated chimeric virus 
at a MOI of 1 and total RNA was extracted and purified at 12 hr after infection. The number of 
viral genome copies in each sample was determined using probes targeting the viral NS1 gene as 
described in the Materials and Methods. (E) To determine the accuracy of loading, the amount of 
GAPDH RNA in each sample was measured to show that the same amount of total RNA was 
used throughout the experiment. Error bars indicate standard deviation of the mean. 
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involved in suppressing early viral RNA synthesis more effectively in cells infected with natural 
WNV strains. 
 
Enhanced early viral RNA synthesis in W956IC-infected cells results in cytoplasmic 
exposure of viral dsRNA 
Viral dsRNA in infected cells is sensed by the pathogen recognition receptors (PRRs), 
PKR, retinoic acid inducible gene I (RIG-I) and melanoma differentiation factor 5 (MDA5) 
(Garcia et al., 2007; Kato et al., 2008). Flavivirus dsRNAs are thought to evade detection by cell 
RNA sensors by localization within ER membrane vesicles (Overby et al., 2010). It was 
previously reported that treating cells with 0.01% Triton X-100 permeabilizes the plasma 
membrane but leaves the intracellular ER membranes intact while 0.1% Triton X-100 solubilizes 
both plasma and ER membranes (Mertens et al., 2010). Differential membrane permeabilization 
was used to assess viral dsRNA membrane association at early times after infection. BHK cells 
were infected with WNV Eg101 or W956IC at a MOI 5 and permeabilized with either 0.1% or 
0.01% Triton X-100 at 12 hr after infection. After fixation and differential permeabilization, the 
cells were analyzed for the presence of viral dsRNA and SGs by confocal microscopy. Viral 
dsRNA was detected in the majority of Eg101- and W956IC-infected cells permeabilized with 
0.1% Triton X-100 (Figure 3.7A). In contrast, after permeabilization with 0.01% Triton X-100, 
viral dsRNA was detected in ~25% of the W956IC-infected cells but in only ~4% of the Eg101-
infected cells (Figure 3.7B). Similar to what was seen with the experiments quantifying SG-
positive, infected cells, W956IC infections produced a higher number of cells with detectable 
dsRNA compared to Eg101 infections (Figure 3.7A). The higher percent of infected cells with 
detectable dsRNA with the 0.01% Triton X-100 treatment was likely due to the use of a MOI of  
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Figure 3.7. Exposed viral dsRNA was detected in 0.01% Triton X-100 permeabilized W956IC-
infected but not Eg101-infected cells. (A) BHK cells were infected with WNV Eg101 or 
W956IC at a MOI of 5, fixed at 12 hr after infection, permeablized with either 0.1% or 0.01% 
Triton X-100 and analyzed by confocal microscopy. Anti-dsRNA antibody (red) was used to 
detect viral dsRNA, anti-G3BP (green) to detect SGs, and Hoechst dye (blue) to detect nuclei. 
Merged images are shown. (B) The total number of cells and the number of dsRNA signal-
positive cells from 0.01% Triton X-100-treated cells were counted and the percentage of cells 
containing detectable dsRNA was determined. 
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5 instead of 1. Importantly, these data also showed that the W956IC-infected cells that contained 
elevated levels of exposed viral dsRNA also contained SGs (Figure 3.7A), suggesting that when 
viral dsRNA is not protected by cytoplamic membranes, it can activate PKR leading to eIF2α 
phosphorylation and SG formation. Why high levels of early viral RNA are produced in a few of 
the WNV Eg101-infected BHK cells and why a maximum of ~20-30% of W956IC-infected cells 
have high levels of early viral RNA is currently not known and suggest that additional cell 
factors may also be involved in the regulation early viral RNA synthesis levels.  
 
DISCUSSION 
The cytoplasmic PRR, PKR, is activated by viral dsRNA. Activated PKR phosphorylates 
Ser51 of eIF2α which attenuates cap-dependent translation and usually leads to the formation of 
SGs. Because the WNV genome is capped, its translation would be expected to be inhibited by 
eIF2α phosphorylation. In contrast, members of other flavivirus genera, such as pestiviruses and 
hepatitis C viruses, initiate translation from an IRES and their translation would not be expected 
to be affected by eIF2α phosphorylation (Robert et al., 2006). Another reason why flavivirus 
infections would benefit from not inducing the formation of SGs is our previous finding that the 
SG-nucleating proteins TIA-1 and TIAR facilitate plus-strand viral RNA synthesis (Emara and 
Brinton, 2008; Li et al., 2002). Infections with viruses have previously been reported to induce 
SGs through PKR activation but only in a subset of the infected cells (Hanley et al., 2010; 
Lindquist et al., 2011b; Venticinque and Meruelo, 2010). Infections with natural lineage 1 and 
lineage 2 strains of WNV did not activate PKR but infections with the chimeric W956IC virus 
did and SG induction by W956IC virus infections was shown to be dependent on PKR. Similar 
to our findings with WNV, infections with a respiratory syncytial virus (RSV) chimeric virus 
78 
 
 
(LeC) induced a higher number of SG-positive, infected cells than natural RSV strain infections 
through the activation of PKR (Groskreutz et al., 2010; Hanley et al., 2010; Lindquist et al., 
2011a; Lindquist et al., 2011b). Although many types of viruses have evolved mechanisms to 
inhibit PKR activation (Garcia et al., 2007), a previous study from our lab showed that WNV 
Eg101 infections do not actively inhibit PKR activation but instead do not activate PKR 
(Elbahesh et al., 2011b). The slight increase in SG-positive, Eg101-infected cells observed at 
later times of infection (from ~1% at 24 hr to ~3% by 36 hr) could be caused by PERK activation 
due to induction of an unfolded protein response (UPR). Natural WNV infections were 
previously reported to induce the UPR at later times of infection (Ambrose and Mackenzie, 
2011). The UPR can activate PERK, another of the eIF2α kinases. Activated PERK was 
previously detected in WNV-infected cells at later times of infection (Ambrose and Mackenzie, 
2011).  
The chimeric junction in the W956IC genome produces a 956D117B3/Eg101 hybrid 
NS5. This hybrid NS5 did not cause a reduction in the replication efficiency of the W956IC virus 
since the yields from Eg101 and W956IC infections were comparable at 24 to 36 hr. In fact, the 
chimeric W956IC virus synthesized RNA more efficiently at early times after infection than did 
Eg101. The increased levels of early viral RNA synthesis observed in W956IC-infected cells 
correlated with an increase in PKR activation and SG formation. The replication of flavivirus 
RNA in infected cells was previously reported to be biphasic (Chu and Westaway, 1985; Cleaves 
et al., 1981). Genomic and complementary minus strand RNAs are replicated symmetrically at 
low levels until about 10 to 12 hr after infection. Thereafter, RNA replication increases 
exponentially and is asymmetric with genome RNA synthesis predominating. The exponential 
increase in viral RNA replication occurs after sufficient virus-induced proliferation and 
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rearrangement of ER membranes has occurred (Lindenbach, 2007). Flavivirus infections as well 
as some other positive-sense RNA virus infections form vesicles in ER membranes that serve as 
the sites of exponential viral RNA synthesis and viral nonstructural proteins have been reported 
to be involved in cytoplasmic membrane remodeling (den Boon and Ahlquist, 2010; Gillespie et 
al., 2010; Welsch et al., 2009). These vesicles open to the cytoplasm through a small pore and 
data from several studies suggest that these vesicles protect viral dsRNA from detection by 
cytoplasmic sensors (den Boon and Ahlquist, 2010; Gillespie et al., 2010; Overby et al., 2010; 
van Hemert et al., 2008; Welsch et al., 2009). 
How flavivirus RNA replication is differentially regulated during the early and late 
phases of viral RNA synthesis is not known. It was previously shown that cyclization of the 
genome through basepairing between 3′ and 5′ RNA sequences was required for RNA replication 
(Basu and Brinton, 2011; Hahn et al., 1987; Zhang et al., 2008). Even though in the chimeric 
W956IC genome, the 3′ cyclization, DAR and UAR sequences were from Eg101 and the 5′ 
cyclization, DAR and UAR sequences were from W956, the long distance 5′-3′ basepairing 
interactions were completely conserved (data not shown). It has also been reported that the WNV 
5′ UTR interacts with the NS5 protein, which contains the methyltransferase and RNA-
dependent RNA polymerase domains. Alteration of this RNA-protein interaction dramatically 
affected the replication efficiency of WNV (Dong et al., 2008). The WNV Eg101 and W956IC 5′ 
UTRs only differ by 1 nt located in a position that was not previously shown to be involved in 
the interaction with NS5, suggesting that this substitution would not affect viral RNA replication 
efficiency. It is possible that the viral nonstructural protein complexes assume different 
conformations during the early and late phases of viral RNA replication. Replication complex 
conformations could be mediated by interactions with different cell partners and/or different 
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cellular membrane microenvironments. The three WNV chimeras that displayed both low levels 
of early viral RNA synthesis and SG induction similar to Eg101 were Eg-NS5, Eg-NS1+3+4a 
and Eg-NS1+5. The polyprotein sequences of Eg101 and W956IC were aligned and revealed a 
number of amino acid changes in the nonstructural proteins as there are 32 aa changes in NS1, 30 
aa changes in NS3+4a, and 33 aa changes in NS5. The majority of these mutations are within the 
same class and are unlikely to modify the function of these proteins. These analyses identified 
five mutations within NS1, NS3+4a and NS5 that are unique to W956IC and D117B956 
compared to the various WNV strains tested and are currently being tested for their effect on 
early viral replication efficiency and SG induction. However, it is more likely that the difference 
in replication efficiencies between these viruses is due to a combination of mutations and not to a 
sole residue mutation as evidenced by the lack of a single viral protein causing the difference in 
SG induction. The finding that chimeras with either an NS5 with both its N- and C-terminal 
regions from Eg101 or a combination of the Eg101 NS1, NS3 and NS4a proteins produced low 
levels of early viral RNA synthesis support the hypothesis that viral nonstructural protein 
conformations and interactions within replication complexes play a role in down-regulating RNA 
synthesis early during natural WNV infections. Similarly, a previous study mapping flavivirus 
nonstructural proteins involved in inhibiting IFN signaling also did not identify a single protein 
as the cause for the difference and further supports the findings of the present study (Ambrose 
and Mackenzie, 2011).  
It is currently not known how viral dsRNA is protected from cytoplasmic RNA sensors 
during early low level symmetric viral RNA synthesis. The results of the present study indicate 
that essentially all of the viral dsRNA present at 12 hr in the majority of Eg101-infected cells 
was associated with cytoplasmic membranes, while some of the dsRNA in ~25% of W956IC 
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virus-infected cells was not. This finding suggests that natural strains of WNV are able to 
carefully match the level of RNA replication with the degree of cytoplasmic membrane 
remodeling. When this coordination is dysregulated, such as in W956IC-infected cells, higher 
levels of early RNA replication exceeds the capacity of the available virus-induced membrane 
protection exposing some of the viral dsRNA and results in PKR activation, eIF2α 
phosphorylation and SG formation. 
 
MATERIALS AND METHODS 
Cells 
All cell lines used were maintained at 37ºC in 5% CO2. Baby hamster kidney 21 strain 
W12 (BHK) cells (Vaheri et al., 1965) and a C3H/He mouse embryo fibroblast (MEF) cell line 
(Scherbik et al., 2006) were maintained in minimal essential medium (MEM) supplemented with 
5% heat-inactivated fetal bovine serum (FBS), glutamine, and 10 µg/ml gentamicin. C57BL/6, 
PERK
+/+
, PKR
-/-
, PERK
-/-
, GCN2
-/-
, and HRI
-/-
 MEFs were maintained in Dulbecco’s Modified 
Eagle Medium (DMEM) supplemented with 10% FBS, glutamine, and 10 µg/ml gentamicin. The 
PERK
-/-
, GCN2
-/-
, and HRI
-/-
 cells are all allelic knockouts, whereas the PKR
-/-
 cells express a 
nonfunctional PKR due to a deletion of the RNA-binding domain found in exons 2-4 (Yang et 
al., 1995). The PERK
+/+
, PERK
-/-
, GCN2
-/-
 and HRI
-/-
 MEFs were provided by David Ron (New 
York University School of Medicine, New York, NY) and the PKR
-/-
 MEFs were provided by 
Robert Silverman (Lerner Research Institute, Cleveland Clinic, Cleveland, OH). 
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Viruses 
WNV Eg101 and W956IC were prepared by infecting BHK cell monolayers at a 
multiplicity of infection (MOI) of 0.1 and harvesting culture fluid at 32 hr after infection. 
Clarified culture fluid was aliquoted and stored at -80ºC. Aliquots of WNV NY99, Tx113, B956, 
Mg78 and SPU were provided by Robert Tesh (University of Texas Medical Branch, Galveston) 
and stocks were grown in BHK cells as described for Eg101. Titers of the virus stocks were: 
Eg101 1x10
8
; W956IC 5x10
7
; NY99 1x10
8
; Tx113 5x10
7
; B956 1x10
7
; Mg78 3x10
6
; and SPU 
7x10
7
. Virus infectivity was assessed by plaque assay on BHK monolayers as previously 
described (Scherbik et al., 2007b). 
 
Construction of chimeric viruses 
The construction of the 956D117B3/Eg101 infectious clone SP6WNEg3′/Xba, here 
referred as W956IC, was described previously (Yamshchikov et al., 2001). The capsid, NS1, 
NS2A, NS3-NS4A, NS4B, NS5 lineage 2 genes or combinations of these genes were replaced in 
the W956IC backbone with the corresponding lineage 1 genes from Eg101. RNA was purified 
from WNV Eg101 and specific cDNA fragments were obtained by RT-PCR amplification using 
specific primers and the SuperScript® One-Step RT-PCR System with Platinum® Taq DNA 
Polymerase (Invitrogen). The primers were designed based on the Eg101 sequence (GenBank# 
AF260968). Nt changes, that did not alter the amino acid sequence, were included in some 
primers to introduce unique restriction sites present in the W956IC sequence. The nt coordinates 
indicated below are from the 956D117B3 sequence (GenBank# M12294). To create a W956IC 
chimera with a capsid gene from Eg101 (Eg-Cap), a fragment containing two unique BglII sites 
(89-465 nts) was amplified from Eg101 RNA and a fragment containing two MfeI sites (465-918 
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nts) was amplified from W965IC, a BglII-MfeI fragment was obtained by overlapping PCR and 
cloned into W956IC. Additional chimeras were created by amplifying the following fragments 
from Eg101 RNA and cloning them into W956IC: Eg-NS1, a MunI (nt 2393) - NsiI (nt 3513) 
fragment; Eg-NS2a, a NsiI (nt 3513) - BstB1 (nt 5135) fragment; Eg-NS3+4a, a BstB1 (nt 5135) 
- SphI (nt 6777) fragment; Eg-NS4b, a SphI (nt 6777) - FseI (nt 7021) fragment; and Eg-NS5, a  
FseI (nt 7021) - AvrII (nt 8901) fragment. For the Eg-NS1+3+4a chimera, a MunI (nt 2393) - 
NsiI (nt 3513) fragment was amplified from Eg101 and cloned to the Eg-NS3+4a chimera and 
for the Eg-NS1+5 chimera, a MunI (nt 2393) - NsiI (nt 3513) fragment was amplified from 
Eg101 and cloned into the Eg-NS5 chimera. All of the chimeric clones were validated by 
sequencing. The sequences of the primers used in this study are available upon request.  
 
Confocal Microscopy 
Confocal microscopy was performed as previously described (Emara and Brinton, 2007). 
Virus-infected cells were detected with anti-dsRNA antibody (English & Scientific Consulting; 
Szirak, Hungary). SGs were detected with anti-G3BP (Ras-GAP-SH3-binding protein) (Abcam 
and Sigma Aldrich). Anti-Dcp1a antibody (a gift from J. Lykke-Anderson; University of 
Colorado, Boulder, CO) was used to detect PBs. AlexaFluor 350-, AlexaFluor 488-, or 
AlexaFluor 594-labeled secondary antibodies (Invitrogen) were diluted in blocking buffer 
containing 0.5 µg/ml Hoechst 33258 dye (Molecular Probes, Bedford, MA) to detect nuclei. 
Images were taken using a LSM 510 confocal microscope (Zeiss, Oberkochen, Germany) with 
either a 63x water-immersion or 100x oil-immersion objective.  Images were analyzed with Zeiss 
LSM Image Browser software. 
 
84 
 
 
SG-Postive Infected Cell Quantification 
A wide-field immunofluorescence microscope with a 40x objective was used to acquire 
images of large fields of WNV-infected cells stained with anti-dsRNA antibody to detect 
infected cells and anti-G3BP to detect SG-positive, infected cells at the indicated times after 
infection and/or treatment. The percentage of SG-positive, infected cells was calculated. 100 
cells per field, from four or more fields of view per treatment, were counted. Quantification was 
done on cells from three separate experiments and statistical significance was determined at a 
95% confidence interval. 
 
Quantification of viral RNA 
In vitro transcribed viral genome RNA of a known concentration was serially diluted and 
used to generate a standard curve (y = -0.2472x + 10.751, where “x” represents the cycle 
threshold (CT)) by real time RT-PCR. This standard curve was then used to determine the 
absolute amount of viral RNA in each cell extract sample. BHK cells were infected with a strain 
of WNV at a MOI of 1 and lysed 12 hr after infection. Total cell RNA was purified using 
TriReagent (Molecular Research Center) according to the manufacturer’s protocol and quantified 
by spectophotometry at OD260. The mean CT value for each RNA sample was determined by real 
time RT-PCR using a probe targeting the WNV NS1 gene. The mean CT value was plotted on 
the standard curve to estimate the number of viral genome copies per 1 µg of total RNA in each 
cellular extract. 
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Western blotting 
Western blot analyses were performed as previously described (Scherbik et al., 2006). 
Primary antibodies include: anti-p-PKR (T451) (Millipore), anti-PKR (SCBT), anti-p-eIF2α 
(Ser51), anti-eIF2α (Cell Signaling), anti-NS3 (R&D Systems), and anti-actin (Abcam). The 
secondary antibodies included anti-rabbit-HRP, anti-mouse-HRP (Cell Signaling), and anti-goat-
HRP (SCBT). All antibodies were diluted in 5% NFDM except for p-PKR and p-eIF2α, which 
were in 5% BSA. 
 
Plaque Assay 
Virus yields were determined as previously described (Scherbik et al., 2007b). 
 
MTT Assay 
Confluent monolayers in 96-well plates were infected with W956IC at a MOI of 1. Virus 
was adsorbed for 1 hr at room temperature and the cells were then incubated in fresh media 
containing different concentrations of 2-aminopurine (2-AP) or DMSO (solvent control) for 24 
hr at 37ºC in 5% CO2. A CellTiter 96® non-radioactive cell proliferation assay was the done 
according to the manufacturer’s protocol (Promega). 
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ADDITIONAL DATA 
 Previous work in the lab showed that WNV Eg101 and dengue 2 virus infections did not 
induce the formation of SGs but inhibited the formation of SGs by oxidative stress (i.e. arsenite 
treatment) (Emara and Brinton, 2007). None of the natural lineage 1 or lineage 2 WNV strains 
tested induced SG formation in infected cells, but that W956IC infections did (Figure 3.1). The 
ability of these additional natural WNV strains and W956IC infections to inhibit the formation of 
arsenite-induced (HRI-mediated) SGs was also tested. BHK cells were infected with WNV 
Eg101, NY99, Tx113, W956IC, B956, Mg78 or SPU at a MOI of 1, treated with 0.5 mM 
arsenite for 30 min prior to fixation at 17 or 24 hr, and analyzed by immunofluorescence. SGs 
were detected in each of the WNV strains at 17 hr after infection (Figure 3.8A) and was 
consistent with previously published data suggesting that the ability of SG inhibition was less 
efficient at earlier times of a WNV infection (Emara and Brinton, 2007). Similar to Eg101, 
infections with each natural WNV strain tested were able to inhibit the formation of SGs by 
arsenite treatment at 24 hr after infection (Figure 3.8B and C). This was also the case for 
W956IC infections that normally induce higher numbers of SG-positive cells. For each virus 
strain tested, the inhibition of SGs at 17 hr after infection was less efficient (Figure 3.8A). These 
results suggest that the ability of WNV strains to inhibit arsenite-induced SG formation increases 
with time after infection. 
 PERK has been reported to be activated by the treatment of cells with dithiothreitol 
(DTT) which causes unfolded proteins to accumulate in the ER and leads to the unfolded protein 
response (Liang et al., 2006). To confirm that DTT treatment induces the formation of SGs, 
BHK cells were treated with 1 mM, 2 mM or 10 mM DTT for 30 min or 60 min prior to fixation 
and analyzed for SGs by immunofluorescence.  The  2  mM  and  10  Mm  DTT  concentrations 
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Figure 3.8. The effect of infections with various WNV strains on arsenite-induced, HRI-
mediated SG formation. BHK cells were infected with individual strains of WNV at a MOI of 
1, treated with 0.5 mM arsenite for 30 min starting at 16.5 hr (A) or at 23.5 hr after infection (B), 
then fixed and analyzed by confocal microscopy. SGs were visualized using either anti-TIAR 
antibody (green) (A) or anti-G3BP antibody (green) (B), WNV-infected cells were visualized 
using anti-dsRNA antibody (red), and cell nuclei were visualized with Hoechst dye (blue). (C) 
SG-positive, infected cells treated with arsenite were quantified.  
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induced higher levels of SGs in BHK cells than 1 mM DTT (Figure 3.9A); however, the 10 mM 
DTT treatment for both 30 and 60 min caused increased cytopathic effects. The 30 min 2 mM 
DTT treatment induced higher levels of SGs than the 60 min treatment and treatment with this 
concentration for 30 min was used for additional experiments. To determine whether WNV 
infections could also inhibit the formation of PERK-induced SGs, BHK cells were infected with 
individual strains of WNV at a MOI of 1, treated with 2 mM DTT at 23.5 hr for 30 min, then 
fixed and analyzed by immunofluorescence. Only B956 infections were found to be able to 
inhibit the formation of DTT-induced, PERK-mediated SG formation; SGs were observed in 
~15% of B956-infected cells and in ~70% of cells infected with the other WNV strains tested 
(Figure 3.9B and C).  
Studies were next done to analyze whether natural WNV infections could inhibit PKR-
induced SG formation. As presented above, W956IC infections induce the formation of SGs 
through the activation of PKR (Figure 3.2). Therefore, BHK cells were infected with W956IC to 
induce the activation of PKR during infection and a natural WNV strain to determine whether 
the natural strain infections could inhibit PKR-induced SG formation. BHK cells were first 
infected with an individual natural WNV strain and then subsequently co-infected with W956IC 
30 min later. Both infections were done at an MOI of 5 to increase the likelihood that most cells 
would be coinfected with both viruses. Cells were fixed at 24 hr after co-infection and analyzed 
by immunofluorescence. SGs were  observed  in ~20±5%  of  the  infected  cells  for  each WNV 
strain co-infected with W956IC, similar to W956IC infections alone, indicating that none of the 
WNV strains tested could inhibit the formation of W956IC-induced, PKR-mediated SGs (Figure 
3.10).  
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Figure 3.9. The effect of various WNV strain infections on DTT-induced, PERK-mediated 
SG formation. (A) BHK cells were treated for 30 or 60 min with 1 mM, 2 mM or 10 mM 
concentrations of DTT to activate PERK and induce SGs. SG-positive cells were quantified. (B) 
BHK cells were infected with individual WNV strains at a MOI of 1, treated with 2 mM DTT for 
30 min prior to fixation at 24 hr after infection, and analyzed by immunofluorescence. SGs were 
visualized with anti-G3BP antibody (green), WNV-infected cells were visualized with anti-
dsRNA antibody (red), and nuclei were visualized with Hoechst dye (blue). (C) SG-positive, 
infected cells were quantified. 
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It has been reported that inhibiting the ubiquitin proteasome system with 10 µM MG132 
leads to GCN2 activation and SG formation (Mazroui et al., 2007). However, no SGs were 
observed in preliminary experiments with this treatment in BHK cells; therefore, it could not be 
determined whether WNV infections could inhibit the formation of GCN2-induced SGs. It has 
been suggested that UV treatment of cells can also induce the formation of SGs through GCN2 
activation; however, experiments testing this treatment have not yet been done. More work is 
required to determine whether infections with natural WNV strains are capable of inhibiting 
GCN2-mediated SG formation. 
Heat shock is another stress known to induce the formation of SGs (Grousl et al., 2009; 
Piotrowska et al., 2010); however, the mechanism of heat shock-induced SG formation in 
mammalian cells is unknown. In yeast cells, heat shock also induces the formation of SGs. 
GCN2 is the only known eIF2α kinase in yeast but gcn2Δ yeast cells treated with heat shock still 
induced the formation of SGs suggesting that SG formation by heat shock treatment is 
independent of eIF2α phosphorylation (Grousl et al., 2009). To determine whether WNV 
infections can inhibit the formation of SGs by heat shock, BHK cells were infected with different 
WNV strains at a MOI of 1 for 24 hr, incubated at 45⁰C for 20 min, then fixed and analyzed for 
SGs by immunofluorescence. None of the WNV strain infections tested inhibited heat shock-
induced SGs (Figure 3.11). Overall, the data from these experiments suggest that the ability of 
WNV infections to inhibit SG formation is specific to the oxidative stress response pathway. 
A preliminary study done by a former member of the lab suggested that the WNV NS5 
protein immunoprecipitated with HRI (data not shown). It is possible that WNV infections 
specifically inhibit HRI-induced SG formation through the inhibition of either HRI activation or  
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Figure 3.10. The effect of various WNV strain infections on W956IC-induced, PKR-
mediated SG formation. (A) BHK cells infected with an individual natural WNV strain and 
then co-infected with W956IC, known to induce PKR-dependent SGs, 30 min later. Each virus 
was used at a MOI of 5 to increase the likelihood of co-infection. Co-infected cells were fixed at 
24 hr and analyzed by immunofluorescence. SGs were visualized using anti-G3BP antibody 
(green), WNV-infected cells were visualized using anti-dsRNA antibody, and nuclei were 
visualized using Hoechst dye (blue). Scale bar represents 20 µm. (B) SG-positive, infected cells 
were quantified. 
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its ability to function as a kinase through an NS5-HRI interaction. To determine whether the 
WNV NS5 protein is able to specifically inhibit HRI-induced SG formation, BHK cells stably 
expressing WNV NS5 were created. These cells were treated with 0.5 mM arsenite for 30 min, 
fixed and analyzed for SG formation by immunofluorescence. The results showed that NS5 
protein expression does not inhibit the formation of HRI-induced SGs (Figure 3.12). However, it 
has recently been suggested that a functional interaction of the NS5 protein with another cell 
protein required in situ protease cleavage from a polyprotein (Ashour et al., 2009). Whether this 
may also be the case for NS5-mediated inhibition of HRI-induced SG formation was not tested. 
Overall, these data show that the inhibition of SG formation by WNV infection is specific to the 
HRI kinase pathway; however, the mechanism of this inhibition is currently under further 
investigation. It is interesting that WNV strains do not induce SG formation during infection but 
that they actively suppress the formation of SGs specific to oxidative stress. Furthermore, the 
efficiency of this suppression increases through the course of infection. It has been reported that 
numerous virus infections induce oxidative stress through the formation of reactive oxygen 
species or nitric oxide (Akaike and Maeda, 2000; Chen et al., 2009; Hosakote et al., 2009; 
Schweizer and Peterhans, 1999; Tardif et al., 2005).  It is possible that the inhibition of HRI-
mediated SG formation by WNV infections is a non-specific byproduct of an active inhibition of 
the antiviral oxidative stress response pathways by viral components in infected cells. 
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Figure 3.11. The effect of various WNV strain infections on heat shock-induced SG 
formation. (A) BHK cells were infected with individual WNV strains at a MOI of 1, incubated 
at 45⁰C for 20 min prior to fixation at 24 hr after infection, and analyzed for SGs by 
immunofluorescence. SGs were visualized using anti-G3BP antibody (green), WNV-infected 
cells were visualized using anti-dsRNA antibody (red), and nuclei were visualized using Hoechst 
dye (blue). (B) SG-positive, infected cells were quantified. 
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Figure 3.12. The effect of WNV NS5 protein expression on arsenite-induced SG formation. 
Control BHK cells or BHK cells stably expressing WNV NS5 (BHK-NS5) were left untreated or 
treated with 0.5 mM arsenite for 30 min, then fixed and analyzed for SGs by 
immunofluorescence. SGs were visualized using anti-G3BP antibody (green) and NS5-
expressing cells were visualized using anti-V5 antibody (red). 
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CHAPTER 4 
 
SIGNIFICANCE/FUTURE DIRECTIONS 
Oas1b-Mediated Resistance to Flavivirus-Induced Disease 
 The majority of the viruses known today were discovered because of a disease they 
caused in an infected host. Advances in technology and therapeutics have substantially improved 
the ability to control viral infections. However, natural genetically-mediated host resistance or 
susceptibility to infectious viruses has been described in both mice and humans (Lee et al., 
2003). One example of the alleles of a single gene conferring resistance or susceptibility to 
disease is Flv
r
, which was shown to confer resistance to flavivirus-induced disease (Webster and 
Clow, 1936; Webster and Johnson, 1941). The product of Flv
r
 was identified as Oas1b, a 
member of the antiviral oligoadenylate synthetase gene family (Mashimo et al., 2002; Perelygin 
et al., 2002). However, additional studies showed that the products of both the resistance and 
susceptibility alleles were inactive synthetases and therefore the specific anti-flaviviral activity 
of Oas1b was not mediated by OAS synthetase activation of RNase L (Elbahesh et al., 2011a; 
Scherbik et al., 2006). The work of the current study was aimed at identifying interaction 
partners of Oas1b as a means of gaining insights about the mechanism of the Oas1b-mediated 
anti-flavivirus activity. To our knowledge, this study is the first to identify host cell binding 
partners of Oas1b.  
One of the binding partners identified was ORP1L, a member of an oxysterol binding 
protein family. It was expected that if ORP1L acted as an antiviral protein, then knocking down 
the levels of this protein would result in an increase in extracellular WNV yield and intracellular 
viral RNA and protein levels; however, a decrease was observed in WNV yield and viral RNA 
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and protein levels. Also, decreases were observed in both SinV and VSV yields, suggesting that 
this proviral effect was not specific to flaviviruses. However, it was previously reported that the 
reduction of ORP1L protein levels increased LE motility (Rocha et al., 2009; Vihervaara et al., 
2011). Each of the viruses showing reduced replication when ORP1L was knocked down utilize 
the host endocytic pathway to enter cells (Chu and Ng, 2004; Lu et al., 1999; Superti et al., 1987) 
and increased LE mobility could negatively affect the efficiency of virion entry and fusion by 
endocytosis. As an additional means of showing that the effect of ORP1L knockdown is not 
specific to the flavivirus resistance mechanism, the effect of ORP1L knockdown on the 
replication of viruses that do not use the endocytic pathway for entry (i.e. vaccinia virus) could 
be tested. 
It was previously reported that overexpression of ORP1L causes clustering of LEs near 
microtubule organizing centers (Rocha et al., 2009; Vihervaara et al., 2011). ORP1L could be 
overexpressed in future experiments to compare the effect on WNV replication in cells 
expressing Oas1b or Oas1bt. If overexpression of ORP1L leads to a decrease in the efficiency of 
WNV infection in both susceptible Oas1bt-expressing and resistant Oas1b-expressing cells, this 
would indicate a non-specific effect of LE clustering which could be analyzed further by 
confocal microscopy using anti-Rab7 antibody to detect LEs. Rab7 was previously shown to 
extensively colocalize with LEs and to interact with ORP1L (Johansson et al., 2005; Rocha et al., 
2009). Alternatively, overexpression of ORP1L could enhance the specific flavivirus resistance 
mechanism since the slowed movement and clustering of LEs in the perinuclear region of cells 
(the preferred site of WNV replication processes) might enhance the ORP1L-Oas1b interaction. 
If this is the case, cells overexpressing ORP1L and Oas1b would provide a good model for 
further studies of the involvement of ORP1L in the flavivirus resistance mechanism. To further 
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determine the flavivirus resistance specificity of the effect of ORP1L overexpression, these cells 
could also be infected with SinV or VSV. The replication of neither of these viruses would be 
expected to be affected if the effect is specific to the flavivirus resistance mechanism. If both 
reducing and increasing ORP1L protein levels causes non-specific effects on LE function, then 
other techniques will be needed to analyze the involvement of ORP1L in the flavivirus resistance 
mechanism. 
The other Oas1b interaction partner identified was ABCF3. ABCF3 was shown to 
mediate WNV-specific antiviral activity. Even though Oas1b was present, WNV replicated to 
higher levels when ABCF3 protein levels were reduced, suggesting that the specific anti-
flaviviral activity of Oas1b depends on the presence of ABCF3. Also, the antiviral activity of 
ABCF3 required the presence of Oas1b, further confirming that the Oas1b-mediated flavivirus 
resistance mechanism involves ABCF3. Currently, nothing is known about the cellular functions 
of the ABCF3 protein except that it belongs to the F subfamily of the superfamily of ATP-
binding cassette-containing proteins. Canonically, these proteins are involved in the transport of 
substrate across membranes but the subfamily E and F members lack the typical transmembrane 
domains required for translocation of substrates across membranes (Hollenstein et al., 2007; 
Locher, 2009). Members of the E and F subfamilies have also been shown to bind translation 
initiation factors and have been suggested that to be involved in regulating protein synthesis 
(Chen et al., 2006; Kerr, 2004; Paytubi et al., 2008; Tyzack et al., 2000). Interestingly, results 
from the current study showed an increase in WNV protein levels, viral RNA and virus yields 
when ABCF3 protein levels were reduced, suggesting that the ABCF3 protein may negatively 
regulate WNV genome translation. Decreased viral translation would negatively affect both viral 
RNA synthesis and virus production. Cellular binding partners of ABCF3 could be identified in 
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future experiments as another means of elucidating its normal cell functions and the mechanism 
of its anti-flaviviral activity.  
Although ABCF3 is normally expressed in cells, its anti-flaviviral function was only 
observed when Oas1b was also present. ABCF3 was also shown to interact with Oas1bt and 
Oas1a in both yeast two-hybrid and in vitro interaction assays. The main difference between 
these Oas1 proteins is their localization within the cell. Oas1b was shown in the present study to 
localize to the ER membrane and is the only member of the OAS family of proteins in any 
species tested so far found to localize to this compartment of the cell. These data imply that the 
interaction between Oas1b and ABCF3 specifically localizes ABCF3 in close proximity to WNV 
RNA translation/replication sites. Future studies could investigate whether ER membrane 
localization of ABCF3 is required for its antiviral affect. ABCF3 cDNA could be cloned into an 
expression vector that fuses a transmembrane ER localization signal to the ABCF3 protein (pER-
ABCF3). The overexpression of this construct in C3H/He (He; Oas1bt-expressing) cells would 
be expected to directly localize ABCF3 to the ER membrane. Control He, He-ABCF3 and He-
ER-ABCF3 cell lines could be created and then infected with WNV and the effect on WNV 
yield, viral RNA and viral protein levels determined. It would be expected that He-ABCF3 cells 
will produce WNV yields similar to the control cells since Oas1b is not expressed in these cells 
and therefore cannot localize ABCF3 to the sites of WNV replication. In contrast, He-ER-
ABCF3 cells might produce reduced viral yields since the ABCF3 protein is localized to the ER 
membrane.  
Knockdown of ORP1L and of ABCF3 was performed using cells stably expressing 
specific shRNAs. However, the levels of these proteins partially recovered during the course of 
infection even though no increase in the levels of these proteins is observed with time after 
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infection in control cells. These data suggest that WNV infections can inhibit the RNAi pathway. 
Other arbovirus infections have been reported to counteract the RNAi pathway in insect cells (Li 
and Ding, 2005; Sanchez-Vargas et al., 2009). However, this ability has not been previously 
reported for flaviviruses. It is expected that Oas1b-expressing mammalian cells and mice with 
ORP1L or ABCF3 gene knockouts would provide better model systems for studying the 
involvement of these proteins in flavivirus genetic resistance. However, it should be noted that 
ORP1L knockout mice may show disease due to the disregulation of endosomes (Vihervaara et 
al., 2011; Yan et al., 2007a). 
The results obtained in this study were used to develop a model for the involvement of 
the Oas1b-ABCF3-ORP1L complex in flavivirus resistance (Figure 4.1). After attachment of 
virion E protein to receptors on susceptible cells (Figure 4.1A), flaviviruses are endocytosed 
through clatherin-coated pits (Chu and Ng, 2004). Previous studies reported that cholesterol-rich 
membrane microdomains in the plasma membrane are required for WNV entry into cells since 
cholesterol-depleted cells failed to internalize WNV particles (Medigeshi et al., 2008). 
Acidification of the endosome leads to conformational changes in E and then LE-specific anionic 
lipids facilitate E-mediated fusion of the viral envelope and host endosomal membranes and 
release of the viral genome (Zaitseva et al., 2010). Movement of LEs along microtubule 
networks requires the recruitment of RILP and ORP1L by Rab7 which is located on the outer 
surface of LEs. RILP in this complex can interact with the p150
Glued
 subunit of the dynein-
dynactin motor complex and mediate LE movement towards the center of the cell (Johansson et 
al., 2005; Johansson et al., 2007). After the release of the viral genome, endosomes either 
continue onto lysosomes for degradation or recycle back to the plasma membrane. Truncated 
Oas1b (Oas1bt) binds to ABCF3 but Oas1bt does not properly localize ABCF3 within the cell 
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for it to exert its anti-flaviviral activity. The tripartite protein complex of Oas1b, ORP1L and 
ABCF3 may be critical to the flavivirus-resistance mechanism. During infection of resistant cells 
(Figure 4.1B), LEs move along the microtubule as described above. In resistant cells, full length 
Oas1b is inserted in the ER membrane and is bound to ABCF3, providing a specific location for 
this antiviral complex within the cell. When LEs move along microtubules and encounter the 
ER-bound Oas1b protein, ORP1L interacts with Oas1b, forming a tripartite protein complex with 
ABCF3. This complex docks the LE. When fusion of the virion with the LE occurs, the genome 
is released near the Oas1b-ABCF3-ORP1L complex, allowing ABCF3 to exert its as yet defined 
anti-flaviviral activity. It is proposed that the LE-associated tripartite protein complex would 
only affect the initial stages of infection. If Oas1b-ABCF3 protein complexes were always bound 
with ORP1L then it would lead to the dysregulation of LEs and thus affect the entry of numerous 
viruses that use the endocytic pathway and would not be specific to flaviviruses. However, the 
fact that ORP1L and ABCF3 bind different regions of Oas1b suggests that each is involved in 
the resistance mechanism. Oas1b-ABCF3 complexes are likely to exist throughout the ER 
membrane where they continually act antiviral towards flaviviruses during the course of an 
infection. The studies presented here showed that DSP treatment was required for consistent 
immunoprecipitation of ORP1L with Oas1b, thus suggesting that this interaction is transient. 
WNV infections induce ER membrane proliferation and ORP1L senses membrane cholesterol 
and it is possible that the transient interaction of Oas1b with ORP1L provides lipid sensing that 
moves these anti-flaviviral protein complexes to regions of virus replication. 
It was previously reported that the ORP1L conformation changes depending on the 
cellular cholesterol levels (Rocha et al., 2009). Future experiments could be done to determine 
the conformation of ORP1L in WNV-infected cells. When cholesterol levels in LEs are high, the 
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ORP1L conformation is closed. This is the conformation expected for virion-containing LEs in 
infected cells since these LEs are expected to contain elevated levels of cholesterol from 
endocytosed cholesterol-rich lipid rafts. Results from the current study showed that Oas1b 
interacts with ORP1L under both mock- and WNV-infected conditions; however, ORP1L was 
overexpressed in these cells and ORP1L as well as LEs were likely clustered in the perinuclear 
area facilitating an interaction with Oas1b on ER membranes. Future studies analyzing the 
ORP1L conformation could be done in resistant or susceptible cells to determine whether the 
presence of Oas1b affects ORP1L conformation. Also, ORP1L conformation studies could also 
be done in mock- and WNV-infected cells to determine whether WNV infections alter the 
conformation of ORP1L. 
It was hypothesized that the interaction between Oas1b and ORP1L leads to the docking 
of LEs but whether this docking is transient or permanent is unknown. Studies have shown that 
VAP-A, an ER integral membrane protein, interacts with ORP1L during low cholesterol 
conditions. Under these conditions, the ORP1L conformation is open, exposing the FFAT motif 
that can interact with VAP-A. This interaction allows VAP-A to remove the p150
Glued
 subunit of 
the dynactin-dynein motor complex inhibiting the movement of the LEs (Rocha et al., 2009). 
Future experiments could be done to determine whether VAP-A removes p150
Glued
 from motor 
complexes in WNV infected resistant cells. Preliminary data indicate that the VAP-A protein 
colocalizes with WNV markers in infected cells at the ER membrane, suggesting that VAP-A 
may be in the same area as the Oas1b-ABCF3-ORP1L protein complex. The dissociation of the 
motor complex by VAP-A could be an additional means by which LE mobility is inhibited in 
WNV-infected resistant cells, thus aiding in the manipulation of the host endocytic pathway so  
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Figure 4.1. Proposed model of Oas1b-ABCF3-ORP1L protein complex. (A) Susceptible cells 
express truncated Oas1b (Oas1bt) that also interacts with ABCF3; however, this complex is not 
localized to the correct compartment of the cell to exert a flavivirus-specific antiviral affect. LEs 
carrying WNV virions release the viral genome at the ER where translation/replication occurs. 
(B) Resistant cells express full length Oas1b that localizes to the ER membrane and forms a 
tripartite complex with ABCF3 and ORP1L. Oas1b binding to ORP1L results in virion fusion 
occurring within close proximity of the Oas1b-ABCF3-ORP1L complex. Translation/replication 
of the viral genome is then exposed to the anti-flaviviral activity of ABCF3. Oas1b-ABCF3 
complexes that may transiently interact with ORP1L likely exist throughout the ER where they 
continue to provide flavivirus specific antiviral activity during the course of an infection. LE-late 
endosome. D-dynein-dynactin motor complex. P-p150
Glued
 subunit of dynactin. 
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that the release of the viral genome occurs in close proximity to the anti-flavivirus protein 
complexes. 
 
SG Formation During WNV Infections 
 The current study confirmed that natural WNV infections do not induce the formation of 
SGs. However, infections with the W956IC infectious clone virus induce SGs through the 
activation of PKR. A previous study showed that natural WNV infections do not activate PKR 
(Elbahesh et al., 2011b) and the data presented here suggest that natural WNV infections do not 
induce the formation of SGs. It is not known how WNV infections evade detection by host cell 
cytoplasmic RNA sensors but data from the current study suggest that infections with natural 
WNV strains suppress the level of their early viral RNA synthesis. In contrast, W956IC 
infections produce higher early levels of viral RNA. During WNV infection, intracellular, 
perinuclear ER membrane vesicles form and are the sites of late exponential viral genome RNA 
synthesis (Gillespie et al., 2010; Welsch et al., 2009). However, it is currently not known what 
type of membrane microenvironment is induced by flavivirus infections to protect viral RNA 
made at early times after infection from cytoplasmic RNA sensors. Previous studies showed that 
a low level of symmetric genome and minus strand viral RNA synthesis is maintained prior to 
the formation of the vesicle structures that support exponential genome RNA synthesis (Cleaves 
et al., 1981). However, W956IC infections do not regulate early RNA synthesis as efficiently and 
so produce increased amounts of viral RNA at early times after infection. The data also suggest 
that an insufficient number of early membrane microenvironments are present to protect the 
increased level of early viral RNA in W956IC-infected cells. Some viral RNA is therefore 
exposed in the cytoplasm which leads to PKR activation, eIF2α phosphorylation and SG 
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formation. It is likely that the membrane microenvironment protecting viral RNA early in 
infection during symmetric viral RNA synthesis differs dramatically from the membrane 
microenvironment that protects viral RNA later in the infection cycle when asymmetric synthesis 
of the viral plus strand occurs. This study is the first to show a correlation between the extent of 
suppression of early RNA replication and induction of the SG response. 
 The mapping data obtained with chimeric virus genomes showed that either NS5, or a 
combination of NS1, NS3 and NS4a, were critical for regulating early viral RNA synthesis and 
controlling the induction of SGs. Each of these nonstructural proteins is a critical component of 
the WNV replication complex and the specific contacts between them, as well as with the viral 
RNA, and possibly other cell proteins, are thought to be important for modulating the efficiency 
of viral RNA synthesis (Brooks et al., 2002; Dong et al., 2008; Johansson et al., 2001; Kapoor et 
al., 1995). There are 24 aa substitutions in NS1, 22 aa substitutions in NS3+4a, and 29 aa 
substitutions in NS5 between the WNV Eg101 and W956IC protein sequences. Future studies 
could be done to identify the critical mutation(s) contributing to the suppression of viral RNA 
synthesis at early times after infection. Data from these studies would provide insights about how 
WNV polymerase function is differentially regulated during the infection cycle. 
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